syndrome	score	normalized_score
FAMILIAL ADENOMATOUS POLYPOSIS 1; FAP1	5.4645201000000005	100.0
MUIR-TORRE SYNDROME; MRTES	5.3239548	97.42767347493148
MULTIPLE ENDOCRINE NEOPLASIA, TYPE I	5.049999	92.41431832229877
BASAL CELL NEVUS SYNDROME	4.59425407	84.07424597084014
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	4.55724563	83.39699638034087
BIRT-HOGG-DUBE SYNDROME	4.4078748	80.66352981298394
NEUROFIBROMATOSIS, TYPE II	4.3562024	79.717931680771
HYPERPARATHYROIDISM 2	3.6384615	66.58336749461311
TUBEROUS SCLEROSIS 2; TSC2	3.1730260000000006	58.06595898512662
TUBEROUS SCLEROSIS	3.1730260000000006	58.06595898512662
LI-FRAUMENI SYNDROME; LFS	3.0077598	55.04160923481643
#606719 MELANOMA-PANCREATIC CANCER SYNDROME;;FAMILIAL ATYPICAL MULTIPLE MOLE MELANOMA-PANCREATIC CARCINOMA SYNDROME;FAMMMPC	2.925	53.52711576630489
PARAGANGLIOMAS 4	2.8185891	51.5798102746479
NEUROFIBROMATOSIS, TYPE III, MIXED CENTRAL AND PERIPHERAL	2.705357	49.50767771903702
#150800 HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER; HLRCC;;MULTIPLE CUTANEOUS AND UTERINE LEIOMYOMATA 1, WITH OR WITHOUT RENALCELL CARCINOMA; MCUL1;;LEIOMYOMATOSIS AND RENAL CELL CANCER, HEREDITARY; LRCC;;LEIOMYOMA, MULTIPLE CUTANEOUS; MCL	2.6602561000000002	48.682337173579064
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	2.555647742	46.768017963736646
PHACE ASSOCIATION	2.500843882	45.7651145248784
COWDEN SYNDROME 7; CWS7	2.3480861	42.96966718083807
#610069 POLYPOSIS SYNDROME, HEREDITARY MIXED, 2; HMPS2	2.2666667	41.479702856248984
STURGE-WEBER SYNDROME	2.25	41.17470443561915
PEUTZ-JEGHERS SYNDROME	2.1954886	40.17715297634278
PARAGANGLIOMAS 1	2.1260117899999997	38.90573647995182
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	2.1088234999999997	38.59119303083906
NEUROFIBROMATOSIS, TYPE I	2.1073771	38.564724100840984
SILVER-RUSSELL SYNDROME; SRS	2.0981288819999997	38.3954829263049
LYSINE-SPECIFIC METHYLTRANSFERASE 2A; KMT2A	2.0714286	37.906871273105935
#180295 RHABDOMYOSARCOMA, EMBRYONAL, 2; RMSE2	2.0384615	37.30357767372838
RETINOBLASTOMA; RB1	2.0202896	36.97103429082455
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	2.0179448	36.92812475884204
COLORECTAL CANCER	1.9435901	35.5674435162202
CARNEY COMPLEX, TYPE 1; CNC1	1.8777770000000003	34.36307243155717
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	1.7666660000000003	32.32975572731446
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	1.76086957	32.22368181974479
CHEMODECTOMA, INTRAABDOMINAL, WITH CUTANEOUS ANGIOLIPOMAS	1.7	31.109776684690022
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	1.7	31.109776684690022
AICARDI SYNDROME; AIC	1.67268869	30.60998329935688
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	1.6694593000000002	30.55088588657584
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	1.571062142	28.750230820818096
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	1.5175335820000002	27.770665204433964
FRONTONASAL DYSPLASIA 1; FND1	1.5129689800000001	27.68713358744897
#608232 LEUKEMIA, CHRONIC MYELOID; CML;;LEUKEMIA, CHRONIC MYELOGENOUS	1.5	27.449802957079427
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	1.4761900000000001	27.014083084807396
PARAGANGLIOMAS 2	1.45	26.534809525176783
#162210 NEUROFIBROMATOSIS, FAMILIAL SPINAL;;FSNF	1.392857	25.489100131592522
#208900 ATAXIA-TELANGIECTASIA; AT;;AT1;;LOUIS-BAR SYNDROMEAT, COMPLEMENTATION GROUP A, INCLUDED; ATA, INCLUDED;;AT, COMPLEMENTATION GROUP C, INCLUDED; ATC, INCLUDED;;AT, COMPLEMENTATION GROUP D, INCLUDED; ATD, INCLUDED;;AT, COMPLEMENTATION GROUP E, INCLUDED; ATE, INCLUDED;;ATAXIA-TELANGIECTASIA VARIANT, INCLUDED	1.3394441600000002	24.511652176007185
#615106 COWDEN SYNDROME 3; CWS3	1.3269231000000001	24.282518422798006
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	1.311954882	24.008601999652264
OVARIAN CANCER	1.3026316	23.837987163776738
234800 HEMANGIOMATOSIS, CUTANEOUS, WITH ASSOCIATED FEATURES	1.2884615	23.578676195188663
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	1.2651515	23.15210625723565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	1.25254453	22.92140036231178
METACHONDROMATOSIS	1.25	22.874835797566192
FAMILIAL ADENOMATOUS POLYPOSIS 3	1.2401316	22.69424537389843
PALLISTER-HALL SYNDROME	1.215129582	22.236711728812196
COSTELLO SYNDROME; CSTLO	1.2000220220000002	21.960245365370696
#602875 ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE; AMDMST. HELENA DYSPLASIA, INCLUDED	1.2	21.959842365663544
THYROID CANCER, NONMEDULLARY, 2; NMTC2	1.2	21.959842365663544
CARNEY-STRATAKIS SYNDROME	1.2	21.959842365663544
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	1.1760127900000001	21.520879573670157
MISMATCH REPAIR CANCER SYNDROME; MMRCS	1.1728002	21.46208959868223
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA	1.166667	21.349852844351325
OSTEOID OSTEOMA	1.166667	21.349852844351325
EXOSTOSES, MULTIPLE, TYPE I	1.166666	21.349834544482686
EXOSTOSES, MULTIPLE, TYPE II	1.166666	21.349834544482686
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	1.142857	20.914132972079287
NEUROFIBROMATOSIS, TYPE IV, OF RICCARDI	1.142857	20.914132972079287
NOONAN SYNDROME 7; NS7	1.1371029400000001	20.80883442994381
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	1.135366882	20.777064796595766
PLATELET DISORDER, UNDEFINED	1.125	20.587352217809574
#132600 PILOMATRIXOMA;;PILOMATRICOMA; PTR;;EPITHELIOMA CALCIFICANS OF MALHERBE	1.125	20.587352217809574
COWDEN SYNDROME 6; CWS6	1.1208567	20.51153037208153
COWDEN SYNDROME 5; CWS5	1.1208567	20.51153037208153
PARAGANGLIOMAS 3	1.116666	20.434841112580038
#609322 RHABDOID TUMOR PREDISPOSITION SYNDROME 1; RTPS1;;BRAIN TUMOR, POSTERIOR FOSSA, OF INFANCY, FAMILIALMALIGNANT RHABDOID TUMOR, SOMATIC, INCLUDED;;RHABDOID TUMOR, INCLUDED; RDT, INCLUDED;;TERATOID TUMOR, ATYPICAL, INCLUDED;;AT/RT, INCLUDED	1.111111	20.333185342295653
DIAPHYSEAL MEDULLARY STENOSIS WITH MALIGNANT FIBROUS HISTIOCYTOMA; DMSMFH	1.1	20.129855501858252
MACROGLOBULINEMIA, WALDENSTROM, SUSCEPTIBILITY TO, 1	1.0869566000000002	19.891162995264672
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	1.0833333	19.824857081228416
OTOSCLEROSIS 7	1.06490139	19.487555549479996
DEAFNESS, AUTOSOMAL DOMINANT 1	1.05810013	19.36309338490675
#156550 KNIEST DYSPLASIA	1.05463568	19.29969440500365
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	1.0454545	19.13168001706133
BRANCHIOOTORENAL SYNDROME 1	1.0416667	19.062363774634115
HEMIHYPERPLASIA, ISOLATED	1.0384615	19.003709035675424
DEAFNESS, AUTOSOMAL DOMINANT 6	1.03125	18.87173953299211
Contractural arachnodactyly, congenital	1.0176799	18.623408485586868
PEROXISOME BIOGENESIS DISORDER 11B	1.00641649	18.417289562170335
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	1.00248756	18.34539065928223
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	1.000843882	18.31531156779897
CURRARINO SYNDROME	1.000843882	18.31531156779897
300270 ADRENOMYODYSTROPHY	1.000843882	18.31531156779897
MESOTHELIOMA, MALIGNANT	1.0	18.299868638052956
POLYPOSIS, INTESTINAL, SCATTERED AND DISCRETE	1.0	18.299868638052956
SALIVARY GLAND ADENOMA, PLEOMORPHIC	1.0	18.299868638052956
#613488 MYXOID LIPOSARCOMA	1.0	18.299868638052956
ANGIOMA, TUFTED	1.0	18.299868638052956
SMALL CELL CANCER OF THE LUNG	1.0	18.299868638052956
HEPATIC ADENOMAS, FAMILIAL	1.0	18.299868638052956
ADIPOSIS DOLOROSA	1.0	18.299868638052956
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	1.0	18.299868638052956
URETER, CANCER OF	1.0	18.299868638052956
#608837 CARNEY COMPLEX VARIANT	1.0	18.299868638052956
IMMUNODEFICIENCY 16	1.0	18.299868638052956
MYELOPROLIFERATIVE SYNDROME, TRANSIENT	1.0	18.299868638052956
CARCINOID TUMORS, INTESTINAL	1.0	18.299868638052956
137245 GASTRIC LYMPHOMA, PRIMARY	1.0	18.299868638052956
SARCOMA, SYNOVIAL	1.0	18.299868638052956
AASE-SMITH SYNDROME I	1.0	18.299868638052956
LYMPHANGIOLEIOMYOMATOSIS	1.0	18.299868638052956
SESSILE SERRATED POLYPOSIS CANCER SYNDROME	1.0	18.299868638052956
TERATOMA, OVARIAN	1.0	18.299868638052956
#606243 ALVEOLAR SOFT PART SARCOMA; ASPS	1.0	18.299868638052956
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	18.299868638052956
#143400 CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 2;;URETEROPELVIC JUNCTION OBSTRUCTION; UPJO;;PELVIURETERIC JUNCTION OBSTRUCTION; PUJO;;HYDRONEPHROSIS DUE TO PUJO;;MULTICYSTIC RENAL DYSPLASIA, BILATERAL; MCRD	1.0	18.299868638052956
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	1.0	18.299868638052956
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	1.0	18.299868638052956
RHABDOMYOSARCOMA 2; RMS2	1.0	18.299868638052956
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	1.0	18.299868638052956
GIGANTIFORM CEMENTOMA, FAMILIAL	1.0	18.299868638052956
CHOLANGIOCARCINOMA	1.0	18.299868638052956
FANCONI-LIKE SYNDROME	1.0	18.299868638052956
ANAL CANAL CARCINOMACLOACOGENIC CARCINOMA, INCLUDED	1.0	18.299868638052956
#612376 ACUTE PROMYELOCYTIC LEUKEMIA; APL;;LEUKEMIA, ACUTE PROMYELOCYTIC	1.0	18.299868638052956
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	1.0	18.299868638052956
%300228 TESTICULAR GERM CELL TUMOR 1; TGCT1	1.0	18.299868638052956
TUMOR PREDISPOSITION SYNDROME; TPDS	0.9894231	18.106312757455132
#615107 COWDEN SYNDROME 4; CWS4	0.933333	17.079871295559876
FAMILIAL ADENOMATOUS POLYPOSIS 4; FAP4	0.9242421	16.9135090197582
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.9125	16.698630132223318
#609265 LI-FRAUMENI SYNDROME 2; LFS2	0.8651316	15.831794634628574
#304150 OCCIPITAL HORN SYNDROME; OHS;;CUTIS LAXA, X-LINKED, FORMERLY;;EHLERS-DANLOS SYNDROME, OCCIPITAL HORN TYPE, FORMERLY;;EDS IX, FORMERLY;;EDS9, FORMERLY	0.8493999899999999	15.543908238163489
#614266 BARRETT ESOPHAGUS;;BARRETT METAPLASIAADENOCARCINOMA OF ESOPHAGUS, INCLUDED	0.833333	15.249884431754582
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.833333	15.249884431754582
TESTICULAR GERM CELL TUMOR; TGCT	0.8125	14.868643268418024
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.7984065	14.610734069767625
PLEUROPULMONARY BLASTOMA	0.777778	14.233235229567551
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10; CRCS10	0.7625	13.953649836515378
EAR EXOSTOSES	0.7527933	13.776018501606387
PROTEUS SYNDROME	0.74796332	13.687630502081966
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.7469865499999999	13.669755739392372
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.74	13.541902792159185
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.71656179	13.112986628048088
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.7	12.809908046637068
MELANOSIS, NEUROCUTANEOUS; NCMS	0.688343882	12.596602618407424
#162091 SCHWANNOMATOSIS;;NEURILEMMOMATOSIS, CONGENITAL CUTANEOUS	0.6842945	12.522499459742129
#612359 COWDEN-LIKE SYNDROME	0.6692986	12.248076459632747
PITUITARY ADENOMA, PROLACTIN-SECRETING	0.666666	12.19990022545621
NEUROFIBROMATOSIS-PHEOCHROMOCYTOMA-DUODENAL CARCINOID SYNDROME	0.644444	11.793240544581398
BECKWITH-WIEDEMANN SYNDROME	0.6313185	11.553045618772634
#137800 GLIOMA SUSCEPTIBILITY 1; GLM1GLIOMA OF BRAIN, FAMILIAL, INCLUDED; GLM, INCLUDED;;GLIOBLASTOMA MULTIFORME, INCLUDED; GBM, INCLUDED;;ASTROCYTOMA, INCLUDED;;OLIGODENDROGLIOMA, INCLUDED;;EPENDYMOMA, INCLUDED;;SUBEPENDYMOMA, INCLUDED	0.6242421	11.423548428342317
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.618406492	11.316757568519144
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.61205957	11.200609729663176
#174900 JUVENILE POLYPOSIS SYNDROME; JPS;;POLYPOSIS, JUVENILE INTESTINAL; PJI;;JUVENILE INTESTINAL POLYPOSIS; JIP;;POLYPOSIS, FAMILIAL, OF ENTIRE GASTROINTESTINAL TRACTJUVENILE POLYPOSIS OF STOMACH, INCLUDED;;JUVENILE POLYPOSIS COLI, INCLUDED	0.5999996999999999	10.97991569287118
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.58587783	10.721487326947521
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.583333	10.674917272241343
IMMUNODEFICIENCY 36; IMD36	0.583333	10.674917272241343
#615670 SCHWANNOMATOSIS 2; SWNTS2	0.583333	10.674917272241343
POLYCYSTIC KIDNEY DISEASE, INFANTILE SEVERE, WITH TUBEROUS SCLEROSIS	0.583333	10.674917272241343
#613013 NEUROBLASTOMA, SUSCEPTIBILITY TO, 2; NBLST2NEUROBLASTOMA WITH HIRSCHSPRUNG DISEASE, INCLUDED	0.583333	10.674917272241343
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.5714286	10.457068316026504
NIJMEGEN BREAKAGE SYNDROME	0.5712562999999999	10.453915248660168
#614337 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 4; HNPCC4	0.566667	10.369931661519553
DESMOID DISEASE, HEREDITARY	0.5666667	10.369926171558962
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.56504453	10.34024067365037
DUBOWITZ SYNDROME	0.5638228599999999	10.31788427313132
KERATOSIS, FAMILIAL ACTINIC	0.5625	10.293676108904787
RHABDOID TUMOR PREDISPOSITION SYNDROME 2; RTPS2	0.5625	10.293676108904787
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12; CRCS12	0.5625	10.293676108904787
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.5625	10.293676108904787
BAZEX SYNDROME; BZX	0.5588235	10.226396641856986
MARDEN-WALKER SYNDROME	0.55241747	10.109167134365558
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.5454545	9.981745698034853
LYMPHOBLASTIC LEUKEMIA, ACUTE, WITH LYMPHOMATOUS FEATURES	0.5434783	9.945581497632334
DIAPHANOSPONDYLODYSOSTOSIS	0.5425105819999999	9.927872385353654
#194080 DENYS-DRASH SYNDROME; DDS;;DRASH SYNDROME;;WILMS TUMOR AND PSEUDO- OR TRUE HERMAPHRODITISM;;NEPHROPATHY, WILMS TUMOR, AND GENITAL ANOMALIES	0.5384615	9.853774716648951
GLIOMA SUSCEPTIBILITY 3	0.5353531	9.796891404974426
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.5315736	9.727727051456906
#148500 TYLOSIS WITH ESOPHAGEAL CANCER; TOC;;KERATOSIS PALMARIS ET PLANTARIS WITH ESOPHAGEAL CANCER	0.53125	9.72180521396563
117600 CEREBRAL SARCOMA	0.53125	9.72180521396563
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.53125	9.72180521396563
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.529316602	9.686424284540557
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.527778	9.658268070054312
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.5157974000000001	9.439024663849256
DEAFNESS AND MYOPIA; DFNMYP	0.50934579	9.320961048345307
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.50934579	9.320961048345307
PAPILLOMA OF CHOROID PLEXUS	0.50724638	9.28254212112789
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.50362319	9.216238220077184
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.503388412	9.211941813518077
ALPORT SYNDROME, X-LINKED; ATS	0.50254453	9.196498883772062
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.5008438820000001	9.165377248772495
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.500843882	9.165377248772494
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	9.149934319026478
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 4; EV4	0.5	9.149934319026478
BURKITT LYMPHOMA; BL	0.5	9.149934319026478
RHABDOMYOSARCOMA 1	0.5	9.149934319026478
PYLORIC STENOSIS, INFANTILE HYPERTROPHIC 1	0.5	9.149934319026478
PULMONARY FIBROSIS, IDIOPATHIC; IPF	0.5	9.149934319026478
MYELOMA, MULTIPLE	0.5	9.149934319026478
ANGIOLIPOMATOSIS, FAMILIAL	0.5	9.149934319026478
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.5	9.149934319026478
MYELOCYTIC LEUKEMIA-LIKE SYNDROME, FAMILIAL, CHRONIC	0.5	9.149934319026478
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.5	9.149934319026478
GAUCHER DISEASE, TYPE I	0.5	9.149934319026478
#603688 PROSTATE CANCER/BRAIN CANCER SUSCEPTIBILITY;;PCBC;;CAPB	0.5	9.149934319026478
HEMANGIOMAS, CAVERNOUS, OF FACE AND SUPRAUMBILICAL MIDLINE RAPHE	0.5	9.149934319026478
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.5	9.149934319026478
TERMINAL OSSEOUS DYSPLASIA; TOD	0.5	9.149934319026478
MYELOCEREBELLAR DISORDER	0.5	9.149934319026478
OVARIAN FIBROMATA	0.5	9.149934319026478
OSSICULAR MALFORMATIONS, FAMILIAL	0.5	9.149934319026478
#234810 PULMONARY VENOOCCLUSIVE DISEASE 2, AUTOSOMAL RECESSIVE; PVOD2;;HEMANGIOMATOSIS, FAMILIAL PULMONARY CAPILLARY	0.5	9.149934319026478
ODONTOMA-DYSPHAGIA SYNDROME	0.5	9.149934319026478
FRASIER SYNDROME	0.5	9.149934319026478
NASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 3	0.5	9.149934319026478
LUNG CANCER	0.5	9.149934319026478
TRICHOEPITHELIOMAS, MULTIPLE DESMOPLASTIC	0.5	9.149934319026478
DEAFNESS, UNILATERAL	0.5	9.149934319026478
#605074 RENAL CELL CARCINOMA, PAPILLARY, 1; RCCP1	0.5	9.149934319026478
%606960 INSULINOMA TUMOR SUPPRESSOR GENE LOCUS	0.5	9.149934319026478
127820 DYSPLASIA EPIPHYSEALIS HEMIMELICA WITH CHONDROMAS AND OSTEOCHONDROMAS;;OSTEOCHONDROMATOSIS, DOMINANT CARPOTARSAL	0.5	9.149934319026478
#612219 EWING SARCOMA; ESNEUROEPITHELIOMA, PERIPHERAL, INCLUDED; PNE, INCLUDED;;ASKIN TUMOR, INCLUDED	0.5	9.149934319026478
%607107 NASOPHARYNGEAL CARCINOMA;;NPCA;;NPC;;NASOPHARYNGEAL CANCERNASOPHARYNGEAL CARCINOMA, SUSCEPTIBILITY TO, 1, INCLUDED; NPCA1, INCLUDED	0.5	9.149934319026478
MASTOCYTOSIS, CUTANEOUS; MASTC	0.5	9.149934319026478
#612160 HISTIOCYTOMA, ANGIOMATOID FIBROUS	0.5	9.149934319026478
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.482549932	8.830600366901384
MELANOMA, CUTANEOUS MALIGNANT	0.475	8.692437603075152
MULTIPLE ENCHONDROMATOSIS, MAFFUCCI TYPE	0.4621215	8.456762744819988
ENCHONDROMATOSIS, MULTIPLE	0.4621215	8.456762744819988
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.45	8.234940887123829
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.4477433599999999	8.193644671560453
OSTEOGENIC SARCOMA	0.43333299999999997	7.9299369765334
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.42752482	7.823648045507235
FRONTOOCULAR SYNDROME	0.419998442	7.685916316786903
ERYTHROLEUKEMIA, FAMILIAL, SUSCEPTIBILITY TO; FERLK	0.4047616	7.407084109728135
46,XY SEX REVERSAL 6; SRXY6	0.392857	7.189231493539569
46,XY SEX REVERSAL 10; SRXY10	0.392857	7.189231493539569
POLYPOSIS, INTESTINAL, WITH MULTIPLE EXOSTOSES	0.392857	7.189231493539569
Familial breast-ovarian cancer-1	0.3859646	7.063101478938654
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.38417733	7.03039467271792
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP E	0.3838235	7.023919630197717
PENDRED SYNDROME	0.3787875	6.931761491736483
Lymphatic malformation 1	0.3787875	6.931761491736483
STORAGE POOL PLATELET DISEASE	0.3749997	6.862445249309267
#215400 CHORDOMA, SUSCEPTIBILITY TO; CHDM	0.37179449999999997	6.803790510350578
THYROID CANCER, NONMEDULLARY, 1; NMTC1	0.366667	6.709957933908963
COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 5	0.366667	6.709957933908963
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.36499122	6.679291380042686
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.364583	6.67182100766726
#278720 XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP C; XPC;;XPCC;;XP, GROUP C;;XERODERMA PIGMENTOSUM III; XP3	0.3588235000000001	6.566422914246395
248100 MACROSOMIA ADIPOSA CONGENITA	0.3529408	6.45877027700932
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.3527933	6.4560710463852065
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.34516635	6.31649886327621
WATSON SYNDROME	0.34285699999999997	6.274238061636921
305350 EPIDERMODYSPLASIA VERRUCIFORMIS, X-LINKED; EDVX; EDV2	0.34285699999999997	6.274238061636921
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.340593372	6.232813966591503
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.3380953	6.187099577143104
ROBERTS SYNDROME; RBS	0.33695619	6.166254013778812
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.33587753	6.146514677473689
FUMARASE DEFICIENCY; FMRD	0.334176882	6.115393042474123
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.334176882	6.115393042474123
#608266 PARATHYROID CARCINOMA;;PRTC	0.333333	6.099950112728105
LEUKEMIA, ACUTE, ?X-LINKED	0.333333	6.099950112728105
MYOFIBROMATOSIS, INFANTILE, 2; IMF2	0.333333	6.099950112728105
HYPERPARATHYROIDISM 4	0.333333	6.099950112728105
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.333333	6.099950112728105
WAGR 11p13 deletion syndrome	0.333333	6.099950112728105
MUNGAN SYNDROME	0.333333	6.099950112728105
ANEMIA, SIDEROBLASTIC, AUTOSOMAL DOMINANT	0.333333	6.099950112728105
CHROMOSOME 13q14 DELETION SYNDROME	0.333333	6.099950112728105
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.333333	6.099950112728105
#601369 DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9	0.333333	6.099950112728105
GASTROESOPHAGEAL REFLUX	0.333333	6.099950112728105
B-CELL CLL/LYMPHOMA 2	0.333333	6.099950112728105
SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	0.333333	6.099950112728105
LEGIUS SYNDROME	0.32681160000000004	5.980609349391907
ZUNICH NEUROECTODERMAL SYNDROME	0.32434579	5.93548535030551
PARAGANGLIOMAS 7; PGL7	0.311111	5.693290431853293
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.29973122	5.485041952723351
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 2; PFBMFT2	0.2934783	5.370614338119097
PULMONARY FIBROSIS AND/OR BONE MARROW FAILURE, TELOMERE-RELATED, 1; PFBMFT1	0.2934783	5.370614338119097
CARBOXYLESTERASE 1	0.2934783	5.370614338119097
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.29255082	5.353641575954675
IMMUNODEFICIENCY 21; IMD21	0.2916667	5.337462296094399
RAS-ASSOCIATED AUTOIMMUNE LEUKOPROLIFERATIVE DISORDER; RALD	0.2869566	5.251268084822306
MYASTHENIA, LIMB-GIRDLE, AUTOIMMUNE	0.28125	5.1468380544523935
THYMOMA, FAMILIAL	0.28125	5.1468380544523935
#202700 NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT; SCN1	0.275	5.032463875464563
SHORT STATURE AND ADVANCED BONE AGE, WITH OR WITHOUT EARLY-ONSET OSTEOARTHRITIS AND/OR OSTEOCHONDRITIS DISSECANS; SSOAOD	0.275	5.032463875464563
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.2745725	5.024640681621795
#608456 FAMILIAL ADENOMATOUS POLYPOSIS, 2; FAP2;;COLORECTAL ADENOMATOUS POLYPOSIS, AUTOSOMAL RECESSIVE;;ADENOMAS, MULTIPLE COLORECTAL, AUTOSOMAL RECESSIVE	0.26666670000000003	4.879965580143076
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.26651569	4.877202116980044
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.26464747	4.84301393639306
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.2634141	4.820443427410944
CROUZON SYNDROME	0.26183335	4.791515910061342
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.26168771	4.788850717192897
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.26122383200000004	4.780361810728814
CHROMOSOME 16p13.3 DELETION SYNDROME	0.260088202	4.759579930907382
GLYCOGEN STORAGE DISEASE Ic; GSD1C	0.2588235	4.736436050441099
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.257295492	4.708473704763205
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.25611075	4.68679308179322
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.25362319	4.641271060563945
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.25347548200000003	4.6385680235671565
NOONAN SYNDROME 6; NS6	0.253388412	4.636974654004841
BOHRING-OPITZ SYNDROME	0.253331442	4.635932110488531
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1; BROVCA1	0.2526316	4.623125093821138
BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 2; BROVCA2	0.2526316	4.623125093821138
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.250843882	4.590410089259256
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.250843882	4.590410089259256
NOONAN SYNDROME 3; NS3	0.250843882	4.590410089259256
B-CELL MALIGNANCY, LOW-GRADE	0.25	4.574967159513239
%613065 LEUKEMIA, ACUTE LYMPHOBLASTIC; ALLLEUKEMIA, ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;ALL1, INCLUDED;;LEUKEMIA, ACUTE LYMPHOCYTIC, SUSCEPTIBILITY TO, 1, INCLUDED;;LEUKEMIA, B-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, T-CELL ACUTE LYMPHOBLASTIC, SUSCEPTIBILITY TO, INCLUDED;;LEUKEMIA, ACUTE LYMPHOBLASTIC, B-HYPERDIPLOID, SUSCEPTIBILITY TO,INCLUDED	0.25	4.574967159513239
ADRENOCORTICAL CARCINOMA, HEREDITARY; ADCC	0.25	4.574967159513239
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.25	4.574967159513239
POLYPS, MULTIPLE AND RECURRENT INFLAMMATORY FIBROID, GASTROINTESTINAL	0.25	4.574967159513239
MELANOMA, UVEAL	0.25	4.574967159513239
RETICULUM CELL SARCOMA	0.25	4.574967159513239
THYROID CARCINOMA, FAMILIAL MEDULLARY	0.25	4.574967159513239
JUVENILE MYELOMONOCYTIC LEUKEMIA	0.25	4.574967159513239
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.25	4.574967159513239
PACHYONYCHIA CONGENITA 2	0.25	4.574967159513239
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.25	4.574967159513239
ADAMS-OLIVER SYNDROME 5; AOS5	0.25	4.574967159513239
LEUKEMIA, CHRONIC LYMPHOCYTIC; CLL	0.25	4.574967159513239
#137215 GASTRIC CANCER, HEREDITARY DIFFUSE; HDGC;;GASTRIC CANCER, FAMILIAL DIFFUSEGASTRIC CANCER, FAMILIAL DIFFUSE, AND CLEFT LIP WITH OR WITHOUT CLEFTPALATE, INCLUDED	0.25	4.574967159513239
ANAUXETIC DYSPLASIA 2; ANXD2	0.25	4.574967159513239
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.25	4.574967159513239
CRANIOACROFACIAL SYNDROME	0.25	4.574967159513239
UPINGTON DISEASE	0.25	4.574967159513239
STEATOCYSTOMA MULTIPLEX WITH NATAL TEETH	0.25	4.574967159513239
KAPOSI SARCOMA, SUSCEPTIBILITY TO	0.25	4.574967159513239
601165 CLEFT LIP/PALATE WITH CHARACTERISTIC FACIES, INTESTINAL MALROTATION,AND LETHAL CONGENITAL HEART DISEASE	0.25	4.574967159513239
#615728 PACHYONYCHIA CONGENITA 4; PC4	0.25	4.574967159513239
LEUKEMIA, ACUTE MONOCYTIC	0.25	4.574967159513239
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.25	4.574967159513239
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.25	4.574967159513239
#613659 GASTRIC CANCERGASTRIC CANCER, INTESTINAL, INCLUDED	0.25	4.574967159513239
MYASTHENIA GRAVIS; MG	0.25	4.574967159513239
#150699 LEIOMYOMA, UTERINE; UL	0.25	4.574967159513239
TERATOMA, PINEAL	0.25	4.574967159513239
HEMANGIOMAS OF SMALL INTESTINE	0.25	4.574967159513239
#612643 DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B	0.25	4.574967159513239
CHROMOSOME 14q32 DUPLICATION SYNDROME, 700-KB	0.25	4.574967159513239
#236000 LYMPHOMA, HODGKIN;;HODGKIN DISEASE	0.25	4.574967159513239
STEATOCYSTOMA MULTIPLEX	0.25	4.574967159513239
MELANOMA, MALIGNANT FAMILIAL INTRAOCULAR	0.25	4.574967159513239
FECHTNER SYNDROME	0.25	4.574967159513239
EHLERS-DANLOS SYNDROME, AUTOSOMAL DOMINANT, TYPE UNSPECIFIED	0.25	4.574967159513239
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.25	4.574967159513239
EXOSTOSES OF HEEL	0.25	4.574967159513239
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.249107	4.558625376819457
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.24721329000000003	4.52397073258089
LYMPHOPROLIFERATIVE SYNDROME 2; LPFS2	0.2434783	4.455620906216449
#127550 DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT, 1; DKCA1;;DYSKERATOSIS CONGENITA, SCOGGINS TYPE	0.2416667	4.422468864191751
ALAGILLE SYNDROME 1; ALGS1	0.23160125	4.238272451408862
OCULOCEREBROCUTANEOUS SYNDROME	0.23125	4.231844622549746
Diamond-Blackfan anemia 1	0.23122916	4.231463253287329
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 3	0.225	4.117470443561914
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.22283472000000001	4.077846103997311
Rothmund-Thomson syndrome	0.21937558000000001	4.014544296396677
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.213003792	3.8979414130071546
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.21240868000000002	3.8870509415822254
OROFACIODIGITAL SYNDROME VI	0.21018967200000002	3.8464433866754377
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.20934579	3.8310004569294196
#278750 XERODERMA PIGMENTOSUM, VARIANT TYPE; XPV;;XERODERMA PIGMENTOSUM WITH NORMAL DNA REPAIR RATES;;PHOTOSENSITIVITY WITH DEFECTIVE DNA SYNTHESIS	0.20882350000000002	3.821442618538452
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.20806452	3.807553384239542
PAPILLORENAL SYNDROME	0.20616772	3.7728421934068828
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.203637182	3.7265336804232816
MICROPHTHALMIA, SYNDROMIC 3	0.20338841200000002	3.7219812221021935
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.203331442	3.7209386785858833
OROFACIODIGITAL SYNDROME I; OFD1	0.2027933	3.7110907506772643
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 1; EV1	0.20168049999999998	3.690726656856838
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.200843882	3.675416657356608
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.2	3.659973727610591
LYMPHOPROLIFERATIVE SYNDROME 3; LPFS3	0.2	3.659973727610591
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.2	3.659973727610591
POLYPOSIS OF GASTRIC FUNDUS WITHOUT POLYPOSIS COLI	0.2	3.659973727610591
NF1-microdeletion syndrome	0.2	3.659973727610591
ENDOMETRIAL CANCER	0.2	3.659973727610591
BLADDER CANCER	0.2	3.659973727610591
IMMUNOERYTHROMYELOID HYPOPLASIA	0.2	3.659973727610591
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 4	0.2	3.659973727610591
#615554 MULTIPLE FIBROADENOMAS OF THE BREAST; MFAB	0.2	3.659973727610591
POLYPOSIS, GASTRIC	0.2	3.659973727610591
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.2	3.659973727610591
#614165 PARAGANGLIOMAS 5; PGL5	0.2	3.659973727610591
THYROID CANCER, NONMEDULLARY, 5; NMTC5	0.2	3.659973727610591
Paragangliomas 6	0.2	3.659973727610591
#608615 OLIGODONTIA-COLORECTAL CANCER SYNDROME; ODCRCS;;TOOTH AGENESIS-COLORECTAL CANCER SYNDROME	0.2	3.659973727610591
PREMATURE OVARIAN FAILURE 8; POF8	0.2	3.659973727610591
THYROID CANCER, NONMEDULLARY, 4; NMTC4	0.2	3.659973727610591
#615706 AURICULOCONDYLAR SYNDROME 3; ARCND3	0.2	3.659973727610591
THYROID CANCER, NONMEDULLARY, 3; NMTC3	0.2	3.659973727610591
CHOROIDAL OSTEOMA, BILATERAL	0.197917	3.621855101237527
OSTEOMA OF MIDDLE EAR	0.19697	3.60452512563729
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.19444430000000001	3.55830514741816
MELANOMA-ASTROCYTOMA SYNDROME	0.1909091	3.493611451808915
PHELAN-MCDERMID SYNDROME; PHMDS	0.18898174199999998	3.458341053590414
PHEOCHROMOCYTOMA	0.1878155	3.4369989781902346
#215300 CHONDROSARCOMA	0.18627480000000002	3.4088043705795865
THROMBOCYTHEMIA, ESSENTIAL	0.18627480000000002	3.4088043705795865
#150250 LARSEN SYNDROME; LRS	0.18562817	3.3969711265221623
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.1855349	3.395264297774291
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.1813185	3.318104731648804
#614456 MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 8; CMM8;;MELANOMA AND RENAL CELL CARCINOMA, SUSCEPTIBILITY TO	0.1769231	3.2376694890371067
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.17628238000000002	3.2259443972033335
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.175	3.202477011659267
MYCOSIS FUNGOIDES	0.1684783	3.083130758362477
CARTILAGE-HAIR HYPOPLASIA; CHH	0.1684783	3.083130758362477
CAPILLARY MALFORMATION-ARTERIOVENOUS MALFORMATION; CMAVM	0.166667	3.049984206298372
#602089 HEMANGIOMA, CAPILLARY INFANTILE;;HCI;;HEMANGIOMA, HEREDITARY CAPILLARY	0.166667	3.049984206298372
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.166667	3.049984206298372
MYELOFIBROSISMYELOFIBROSIS WITH MYELOID METAPLASIA, INCLUDED	0.166667	3.049984206298372
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE I; HHC1	0.166667	3.049984206298372
#256050 ATELOSTEOGENESIS, TYPE II; AOII;;AO2;;NEONATAL OSSEOUS DYSPLASIA IDE LA CHAPELLE DYSPLASIA, INCLUDED; DLCD, INCLUDED	0.166667	3.049984206298372
#614385 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 7; HNPCC7	0.166667	3.049984206298372
#613244 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 8; HNPCC8	0.166667	3.049984206298372
GOITER, MULTINODULAR 1	0.166667	3.049984206298372
PANCREATIC CANCER	0.166667	3.049984206298372
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.166667	3.049984206298372
CRANIOLENTICULOSUTURAL DYSPLASIA	0.166667	3.049984206298372
#108721 ATELOSTEOGENESIS, TYPE III; AOIII;;AO3	0.166667	3.049984206298372
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.166667	3.049984206298372
#612237 CHONDROSARCOMA, EXTRASKELETAL MYXOID;;EMC	0.166667	3.049984206298372
SPONDYLOCOSTAL DYSOSTOSIS 6, AUTOSOMAL RECESSIVE; SCDO6	0.166667	3.049984206298372
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.166667	3.049984206298372
TROPICAL CALCIFIC PANCREATITIS	0.166667	3.049984206298372
MYELOPROLIFERATIVE DISEASE, AUTOSOMAL RECESSIVE	0.166667	3.049984206298372
#610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM	0.166667	3.049984206298372
#613347 PANCREATIC CANCER, SUSCEPTIBILITY TO, 2;;PNCA2	0.166667	3.049984206298372
OSTEOMAS OF MANDIBLE	0.166667	3.049984206298372
#614331 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6; HNPCC6;;COLON CANCER, HEREDITARY NONPOLYPOSIS, TYPE 6	0.166667	3.049984206298372
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.166667	3.049984206298372
WERNER SYNDROME; WRN	0.16612319	3.040032554734312
GLYCEROL KINASE DEFICIENCY; GKD	0.16610310199999997	3.0396649469731103
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.15987319	2.9256583757464814
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.15685878199999997	2.8704951053249848
MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVE NEOPLASMS, FAMILIAL (MULTIPLE TYPES), SUSCEPTIBILITY TO; MPLPF	0.1565736	2.865276312187048
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.14618425000000002	2.675152571952293
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.14528368200000003	2.658672295852659
TURNPENNY-FRY SYNDROME; TPFS	0.14480505200000002	2.649913429726427
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.14370088199999997	2.6297072637723478
MULTIPLE EXOSTOSES WITH SPASTIC TETRAPARESIS	0.14285699999999998	2.6142643340263305
EXOSTOSES WITH ANETODERMIA AND BRACHYDACTYLY, TYPE E	0.14285699999999998	2.6142643340263305
GONADOBLASTOMA	0.14285699999999998	2.6142643340263305
46,XY SEX REVERSAL 1; SRXY1	0.14285699999999998	2.6142643340263305
#614868 T-CELL IMMUNODEFICIENCY, RECURRENT INFECTIONS, AND AUTOIMMUNITY WITHOR WITHOUT CARDIAC MALFORMATIONS; TIIAC;;STK4 DEFICIENCY;;MST1 DEFICIENCY	0.14285699999999998	2.6142643340263305
IMMUNODEFICIENCY 58; IMD58	0.14285699999999998	2.6142643340263305
WHIM SYNDROME	0.14285699999999998	2.6142643340263305
#613860 IMMUNODEFICIENCY DUE TO FICOLIN 3 DEFICIENCY;;FICOLIN 3 DEFICIENCY;;FCN3 DEFICIENCY	0.14285699999999998	2.6142643340263305
LERI-WEILL DYSCHONDROSTEOSIS	0.14285699999999998	2.6142643340263305
#182000 KERATOSIS, SEBORRHEIC	0.14285699999999998	2.6142643340263305
Potocki-Shaffer syndrome	0.14285699999999998	2.6142643340263305
POTOCKI-SHAFFER SYNDROME	0.14285699999999998	2.6142643340263305
46,XY SEX REVERSAL 7	0.14285699999999998	2.6142643340263305
EXOSTOSES, MULTIPLE, TYPE III	0.14285699999999998	2.6142643340263305
BRANCHIOOCULOFACIAL SYNDROME	0.14153168	2.5900111521229463
CHROMOSOME Xq26.3 DUPLICATION SYNDROME	0.14	2.5619816093274137
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.1374577	2.5154578532888916
BLOOM SYNDROME	0.1369566	2.5062877891143636
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.13585782	2.486180259452243
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.135847442	2.485990343415518
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.13479090999999999	2.466655946603618
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.13465679	2.4642015682218825
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.13461538	2.463443770661581
FIBROMATOSIS, GINGIVAL, 5; GINGF5	0.13438740000000002	2.4592717666094774
GLIOMA SUSCEPTIBILITY 9; GLM9	0.13438740000000002	2.4592717666094774
OROFACIODIGITAL SYNDROME XIV; OFD14	0.132600642	2.426574329921487
RETT SYNDROME; RTT	0.13145161	2.405547195260568
%165660 OSLAM SYNDROME;;OSTEOSARCOMA, LIMB ANOMALIES, AND MACROCYTOSIS;;OSTEOSARCOMA, LIMB ANOMALIES, AND ERYTHROID MACROCYTOSIS WITH MEGALOBLASTICMARROW	0.13125	2.40185775874445
104600 AMENORRHEA-GALACTORRHEA SYNDROME	0.13125	2.40185775874445
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.13116772	2.4003520455529106
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.128637182	2.3540435325693094
PETTIGREW SYNDROME	0.128388412	2.3494910742482213
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL RECESSIVE, LEROY-SPRANGERTYPE	0.12820518	2.346137952717934
XFE PROGEROID SYNDROME; XFEPS	0.1277933	2.338600602823292
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.1277933	2.338600602823292
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.12754453	2.334048144502204
#613707 LEOPARD SYNDROME 3; LPRD3	0.12754453	2.334048144502204
DE SANCTIS-CACCHIONE SYNDROME	0.12754453	2.334048144502204
DEAFNESS, X-LINKED 4	0.12754453	2.334048144502204
OROFACIODIGITAL SYNDROME XVI; OFD16	0.125843882	2.3029265095026363
#613091 ASPHYXIATING THORACIC DYSTROPHY 3; ATD3	0.125	2.2874835797566195
POROKERATOSIS 1, MULTIPLE TYPES; POROK1	0.125	2.2874835797566195
XERODERMA PIGMENTOSUM, AUTOSOMAL DOMINANT, MILD	0.125	2.2874835797566195
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.125	2.2874835797566195
CYLINDROMATOSIS, FAMILIAL	0.125	2.2874835797566195
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.125	2.2874835797566195
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.125	2.2874835797566195
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.125	2.2874835797566195
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.125	2.2874835797566195
OROFACIODIGITAL SYNDROME IV; OFD4	0.125	2.2874835797566195
HISTIOCYTOSIS, PROGRESSIVE MUCINOUS	0.125	2.2874835797566195
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.125	2.2874835797566195
#612644 DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B	0.125	2.2874835797566195
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 10; CMM10	0.125	2.2874835797566195
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.125	2.2874835797566195
NEVUS, KERATINOCYTIC, NONEPIDERMOLYTIC	0.125	2.2874835797566195
#300455 RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITHOR WITHOUT DEAFNESS	0.125	2.2874835797566195
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 9; CMM9	0.125	2.2874835797566195
OCULOSKELETODENTAL SYNDROME; OCSKD	0.12403858200000002	2.26988975665036
ZIMMERMANN-LABAND SYNDROME 1	0.12232559000000001	2.2385422280723244
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.1221591	2.235495482942775
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.1185898	2.170177761812972
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.1169231	2.139677370753929
RAMON SYNDROME	0.11530551	2.110075686243701
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.11393918200000001	2.085072063327208
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.11340219999999998	2.0752453632662085
MONOSOMY 7 OF BONE MARROW	0.11309530000000001	2.0696291335811905
CHEILITIS GLANDULARIS	0.1125	2.058735221780957
PALMOPLANTAR CARCINOMA, MULTIPLE SELF-HEALING; MSPC	0.1125	2.058735221780957
LICHEN SCLEROSUS ET ATROPHICUS; LSA	0.1125	2.058735221780957
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.11234252	2.0558533584678367
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.11189032	2.0475781578697094
LIPOMATOSIS, FAMILIAL BENIGN CERVICAL	0.11111099999999999	2.0333167042427016
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.11111099999999999	2.0333167042427016
MEDULLOBLASTOMA	0.11111099999999999	2.0333167042427016
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.11111099999999999	2.0333167042427016
LIPOMA OF THE CONJUNCTIVA	0.11111099999999999	2.0333167042427016
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.11111099999999999	2.0333167042427016
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.10954818	2.0047173035377797
EPIDERMODYSPLASIA VERRUCIFORMIS, SUSCEPTIBILITY TO, 3; EV3	0.1088235	1.9914557547331557
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.10645161	1.9480504793092441
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.1055556	1.9316536140108624
OROFACIODIGITAL SYNDROME VIII; OFD8	0.10333144200000001	1.890951814780588
OROFACIODIGITAL SYNDROME IX; OFD9	0.10333144200000001	1.890951814780588
PAGET DISEASE OF BONE 3; PDB3	0.1027933	1.881103886871969
CZECH DYSPLASIA, METATARSAL TYPE	0.10192310000000002	1.8651793411831354
HAMARTOMA, PRECALCANEAL CONGENITAL FIBROLIPOMATOUS	0.1	1.8299868638052954
BASALOID FOLLICULAR HAMARTOMA SYNDROME, GENERALIZED, AUTOSOMAL DOMINANT; GBFHS	0.1	1.8299868638052954
LIP, HAMARTOMATOUS	0.1	1.8299868638052954
PITUITARY ADENOMA 2, GROWTH HORMONE-SECRETING; PITA2	0.1	1.8299868638052954
PITUITARY ADENOMA 5, MULTIPLE TYPES; PITA5	0.1	1.8299868638052954
MELANOMA, CUTANEOUS MALIGNANT, SUSCEPTIBILITY TO, 2	0.1	1.8299868638052954
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.1	1.8299868638052954
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.1	1.8299868638052954
THAUVIN-ROBINET-FAIVRE SYNDROME	0.09862317200000001	1.8047910922681023
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.09766586000000001	1.7872724084224707
ALSTROM SYNDROME; ALMS	0.09736899199999999	1.7818397630196288
TIETZ SYNDROME	0.0954545	1.7468048109110255
#602398 DESMOSTEROLOSIS	0.09424054200000001	1.7245895389789125
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.09113873200000001	1.6678268234387135
FIBROMATOSIS, GINGIVAL, 1	0.0909091	1.6636245880036198
HYALINE FIBROMATOSIS SYNDROME; HFS	0.0909091	1.6636245880036198
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.0909091	1.6636245880036198
DEAFNESS, AUTOSOMAL DOMINANT 50	0.08935013	1.6350956417929545
VELOCARDIOFACIAL SYNDROME	0.0891265	1.6310032421694265
NOONAN SYNDROME 2; NS2	0.08780048200000001	1.606737286957733
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.08680560000000001	1.5885310770473695
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.08612660000000001	1.5761054662421317
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.085988882	1.5735852449330363
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.085145	1.5581423151870186
#614082 FANCONI ANEMIA, COMPLEMENTATION GROUP G; FANCG	0.085145	1.5581423151870186
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.08498762000000001	1.5552622818607622
HUNTER-MACDONALD SYNDROME	0.08400569999999999	1.5372932748476849
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.08333330000000001	1.5249884431754586
LIPOMATOSIS, MULTIPLE	0.08333330000000001	1.5249884431754586
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE II	0.08333330000000001	1.5249884431754586
EAR WAX, WET/DRY	0.0829346	1.5176922855494663
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.08182254200000001	1.4973417702315708
DEAFNESS, AUTOSOMAL DOMINANT 20	0.08125	1.4868643268418025
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.08025454200000001	1.4686475762071038
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.0801282	1.4663355342036346
HYPERCALCEMIA, INFANTILE, 1	0.07922778	1.449857966484559
KBG SYNDROME	0.07776698200000001	1.4231255549778288
N SYNDROME	0.0775216	1.4186350966116856
RENAL CELL CARCINOMA, NONPAPILLARY	0.07692310000000001	1.4076826252318113
SJOGREN-LARSSON SYNDROME; SLS	0.07692310000000001	1.4076826252318113
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.07692310000000001	1.4076826252318113
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.07692310000000001	1.4076826252318113
#601894 GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 2; GFND2;;GLOMERULAR NEPHRITIS, FAMILIAL, WITH FIBRONECTIN DEPOSITS;;FIBRONECTIN GLOMERULOPATHY	0.07692310000000001	1.4076826252318113
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.07692310000000001	1.4076826252318113
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.07692310000000001	1.4076826252318113
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.07692310000000001	1.4076826252318113
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.07692310000000001	1.4076826252318113
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.07692310000000001	1.4076826252318113
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.07692310000000001	1.4076826252318113
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.07692310000000001	1.4076826252318113
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.07692310000000001	1.4076826252318113
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.07692310000000001	1.4076826252318113
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.07692310000000001	1.4076826252318113
#300854 RENAL CELL CARCINOMA, Xp11-ASSOCIATED; RCCX1	0.07692310000000001	1.4076826252318113
#601869 DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15;;DEAFNESS, AUTOSOMAL RECESSIVE 72; DFNB72;;DEAFNESS, AUTOSOMAL RECESSIVE 95; DFNB95	0.07692310000000001	1.4076826252318113
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.07692310000000001	1.4076826252318113
MUCOLIPIDOSIS III GAMMA	0.07489049	1.3704861292394184
IMMUNODEFICIENCY, COMMON VARIABLE, 2; CVID2	0.0747283	1.3675180735450125
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0744235	1.361940273584134
RUIJS-AALFS SYNDROME; RJALS	0.073975	1.3537327824999672
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.07306452	1.3370711181023927
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.0729167	1.3343660315203159
#607847 NEUTROPENIA, NONIMMUNE CHRONIC IDIOPATHIC, OF ADULTS;;NONIMMUNE CHRONIC IDIOPATHIC NEUTROPENIA OF ADULTS;;NI-CINA	0.07142860000000001	1.3071339970000293
DOHLE BODIES AND LEUKEMIA	0.07142860000000001	1.3071339970000293
LEUKEMIA, ACUTE MYELOID; AML	0.07142860000000001	1.3071339970000293
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.06961751999999999	1.273991470907024
FRYNS MICROPHTHALMIA SYNDROME	0.0687645	1.2583813169613924
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.067127872	1.228431239552033
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.06688802	1.2240419794594588
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3	0.0666667	1.2199918525324849
METHANE PRODUCTION	0.0666667	1.2199918525324849
#609310 COLORECTAL CANCER, HEREDITARY NONPOLYPOSIS, TYPE 2; HNPCC2;;COLON CANCER, FAMILIAL NONPOLYPOSIS, TYPE 2; FCC2;;COCA2	0.0666667	1.2199918525324849
LYNCH SYNDROME I	0.0666667	1.2199918525324849
IMMUNODEFICIENCY 61; IMD61	0.0666667	1.2199918525324849
SMITH-MCCORT DYSPLASIA 2; SMC2	0.06643357999999999	1.2157257871555818
Fabry disease	0.06606988	1.209070124931922
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.06606988	1.209070124931922
WIDOW&#39;S PEAK SYNDROME	0.06527511	1.1945259383344569
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.06517098	1.1926203730131764
HALLERMANN-STREIFF SYNDROME; HSS	0.06493425	1.18828824511049
#607174 MENINGIOMA, FAMILIAL, SUSCEPTIBILITY TO	0.0625	1.1437417898783098
ALKAPTONURIA	0.061754609999999995	1.1301012507941912
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.0616168	1.1275793458971812
#172800 PIEBALD TRAIT; PBT;;PIEBALDISM	0.061553	1.1264118142780732
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.061368030000000004	1.123026887576093
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.060022672000000006	1.0984070129049393
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.05936281	1.0863316249856962
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.05934659999999999	1.0860349841150732
#137440 GERSTMANN-STRAUSSLER DISEASE; GSD;;ENCEPHALOPATHY, SUBACUTE SPONGIFORM, GERSTMANN-STRAUSSLER TYPE;;GERSTMANN-STRAUSSLER-SCHEINKER DISEASE; GSS;;CEREBELLAR ATAXIA, PROGRESSIVE DEMENTIA, AND AMYLOID DEPOSITS IN CNS;;AMYLOIDOSIS, CEREBRAL, WITH SPONGIFORM ENCEPHALOPATHY;;PRION DEMENTIACEREBRAL AMYLOID ANGIOPATHY, PRNP-RELATED, INCLUDED	0.0588235	1.076462322830508
#603471 CITRULLINEMIA, TYPE II, ADULT-ONSET; CTLN2;;CITRIN DEFICIENCY	0.0588235	1.076462322830508
GLYCOGEN STORAGE DISEASE IA	0.0588235	1.076462322830508
Yao syndrome	0.0588235	1.076462322830508
DERMOCHONDROCORNEAL DYSTROPHY	0.0588235	1.076462322830508
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.0588235	1.076462322830508
#266600 INFLAMMATORY BOWEL DISEASE 1; IBD1REGIONAL ENTERITIS, INCLUDED;;CROHN DISEASE, INCLUDED;;ULCERATIVE COLITIS, INCLUDED;;CROHN DISEASE-ASSOCIATED GROWTH FAILURE, SUSCEPTIBILITY TO, INCLUDED	0.0588235	1.076462322830508
245800 LAURENCE-MOON SYNDROME	0.0588235	1.076462322830508
BUDD-CHIARI SYNDROMEMEMBRANOUS OBSTRUCTION OF INFERIOR VENA CAVA, INCLUDED	0.0588235	1.076462322830508
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.0588235	1.076462322830508
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC, 4	0.0588235	1.076462322830508
PERRY SYNDROME	0.0588235	1.076462322830508
ROMBO SYNDROME	0.0588235	1.076462322830508
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.0588235	1.076462322830508
WILSON DISEASE	0.0588235	1.076462322830508
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 2; TTPP2	0.0588235	1.076462322830508
HEMOCHROMATOSIS, TYPE 1	0.0588235	1.076462322830508
PARKINSON DISEASE 4, AUTOSOMAL DOMINANT LEWY BODY	0.0588235	1.076462322830508
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH SEVERE PROXIMAL FEMORAL DYSPLASIA	0.0588235	1.076462322830508
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.0588235	1.076462322830508
TRICHOEPITHELIOMA, MULTIPLE FAMILIAL, 1	0.0588235	1.076462322830508
TYROSINEMIA, TYPE I; TYRSN1	0.0588235	1.076462322830508
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.0588235	1.076462322830508
GLYCOGEN STORAGE DISEASE IB	0.0588235	1.076462322830508
THYROTOXIC PERIODIC PARALYSIS, SUSCEPTIBILITY TO, 1; TTPP1	0.0588235	1.076462322830508
HUNTINGTON DISEASE-LIKE 2	0.0588235	1.076462322830508
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.0588235	1.076462322830508
HEPATOCELLULAR CARCINOMA	0.0588235	1.076462322830508
ATYPICAL MYCOBACTERIOSIS, FAMILIAL	0.0588235	1.076462322830508
ALPHA-1-ANTITRYPSIN DEFICIENCY; A1ATD	0.0588235	1.076462322830508
EPISODIC ATAXIA, TYPE 1; EA1	0.0588235	1.076462322830508
CHOLESTASIS, PROGRESSIVE FAMILIAL INTRAHEPATIC 2	0.0588235	1.076462322830508
PORPHYRIA CUTANEA TARDA	0.0588235	1.076462322830508
#256850 GIANT AXONAL NEUROPATHY 1, AUTOSOMAL RECESSIVE; GAN1;;GAN	0.0588235	1.076462322830508
BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 1; BCC1	0.0588235	1.076462322830508
INFLAMMATORY BOWEL DISEASE 11	0.0588235	1.076462322830508
%275000 GRAVES DISEASE;;GRD;;THYROTOXICOSIS;;HYPERTHYROIDISM, AUTOIMMUNEGRAVES DISEASE, SUSCEPTIBILITY TO, 1, INCLUDED; GRD1, INCLUDED	0.0588235	1.076462322830508
MACS SYNDROME	0.0586298	1.0729176382753172
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.05810013000000001	1.0632247468537996
DEAFNESS, MID-TONE NEURAL	0.05810013000000001	1.0632247468537996
COFFIN-SIRIS SYNDROME 1; CSS1	0.058030851999999994	1.0619569685542922
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.05791246	1.0597904105064961
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.05773368999999999	1.0565189429900712
300106 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED;;SEMD, X-LINKED; SEMDX	0.05773368999999999	1.0565189429900712
MIRAGE SYNDROME; MIRAGE	0.05766208199999999	1.0552085259966375
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.05728785	1.048360129556482
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.05724638	1.047601234004062
ANDROGEN INSENSITIVITY SYNDROME	0.05625	1.0293676108904786
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.05625	1.0293676108904786
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.055555600000000004	1.0166601821082148
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.055555600000000004	1.0166601821082148
PERRAULT SYNDROME 4	0.055555600000000004	1.0166601821082148
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.055555600000000004	1.0166601821082148
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.055555600000000004	1.0166601821082148
#613453 DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91	0.055555600000000004	1.0166601821082148
PEROXISOME BIOGENESIS DISORDER 14B	0.055555600000000004	1.0166601821082148
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.055555600000000004	1.0166601821082148
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.0555405	1.01638385409178
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.0542857	0.9934211789247513
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.053623472	0.9813024935163107
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.05362319	0.9812973329533548
WHITE-SUTTON SYNDROME; WHSUS	0.053331442	0.9759583828779401
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.0527933	0.9661104549693209
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.052700880000000005	0.9644191811097923
#614564 CUTANEOUS TELANGIECTASIA AND CANCER SYNDROME, FAMILIAL; FCTCS;;TELANGIECTASIA, CUTANEOUS, AND CANCER SYNDROME, FAMILIAL	0.0526316	0.9631513662105478
BREAST CANCER	0.0526316	0.9631513662105478
#602540 ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS;;HID SYNDROME	0.052544530000000006	0.9615579966482327
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.052544530000000006	0.9615579966482327
INFANTILE SIALIC ACID STORAGE DISEASE	0.052502082	0.9607812038242844
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.05248756	0.9605154531319228
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.051282079999999994	0.9384553274861225
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.051282079999999994	0.9384553274861225
SPONDYLOCOSTAL DYSOSTOSIS 5	0.051282079999999994	0.9384553274861225
NOONAN SYNDROME 5; NS5	0.051078942	0.9347379287707258
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.050911609999999996	0.9316757751517831
MORQUIO SYNDROME A	0.050911609999999996	0.9316757751517831
Temtamy preaxial brachydactyly syndrome	0.050843882	0.9304363616486652
ACROCRANIOFACIAL DYSOSTOSIS	0.050351820000000005	0.9214316916868877
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.05	0.9149934319026477
CHROMOSOME 17q12 DELETION SYNDROME	0.05	0.9149934319026477
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.05	0.9149934319026477
CANCER, ALOPECIA, PIGMENT DYSCRASIA, ONYCHODYSTROPHY, AND KERATODERMA; CAPOK	0.05	0.9149934319026477
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.05	0.9149934319026477
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.05	0.9149934319026477
SQUAMOUS CELL CARCINOMA, HEAD AND NECK	0.05	0.9149934319026477
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.05	0.9149934319026477
ESOPHAGEAL CANCER	0.05	0.9149934319026477
#613988 DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE, 3; DKCB3	0.05	0.9149934319026477
ACNE INVERSA, FAMILIAL, 2, WITH OR WITHOUT DOWLING-DEGOS DISEASE; ACNINV2	0.05	0.9149934319026477
#610265 DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67	0.05	0.9149934319026477
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.05	0.9149934319026477
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.05	0.9149934319026477
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.05	0.9149934319026477
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.04992991000000001	0.9137107941098068
WEAVER SYNDROME	0.049783051999999994	0.9110233120013593
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.04973121999999999	0.9100747932101116
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.04973121999999999	0.9100747932101116
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.04960304200000001	0.9077291526478235
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.049354272000000005	0.9031766943267352
FANCONI ANEMIA	0.04875916	0.8922862229018061
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.04875916	0.8922862229018061
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.04875916	0.8922862229018061
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.048651172	0.89031005668732
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.048549702	0.8884531690166169
IMMUNODEFICIENCY 55; IMD55	0.048423459999999995	0.8861429570000116
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0482478	0.8829284020750514
#607326 SMITH-MCCORT DYSPLASIA 1; SMC1;;SMC	0.04811831	0.8805587520851098
#313400 SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, X-LINKED; SEDT;;SED TARDA, X-LINKED;;SPONDYLOEPIPHYSEAL DYSPLASIA, LATE	0.04811831	0.8805587520851098
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.04794206	0.877333400237653
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.047834419999999996	0.8753636023774529
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.04780729	0.8748671269413026
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.04780729	0.8748671269413026
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.047295491999999995	0.8655012907720843
LOEYS-DIETZ SYNDROME 3; LDS3	0.04710149	0.8619510796565649
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.046809742	0.8566121295811502
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.04669879	0.8545817225560208
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.046298382	0.8472543087543953
WT LIMB-BLOOD SYNDROME	0.04602283000000001	0.8422117433514428
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.045721872	0.8367042514858715
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.0454545	0.831811379008378
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.0454545	0.831811379008378
#263400 ERYTHROCYTOSIS, FAMILIAL, 2; ECYT2;;ERYTHROCYTOSIS, AUTOSOMAL RECESSIVE BENIGN;;POLYCYTHEMIA, VHL-DEPENDENT;;POLYCYTHEMIA, CHUVASH TYPE	0.0454545	0.831811379008378
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0454545	0.831811379008378
HEMANGIOMA-THROMBOCYTOPENIA SYNDROME	0.0454545	0.831811379008378
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.0454545	0.831811379008378
DEAFNESS-OLIGODONTIA SYNDROME	0.0454545	0.831811379008378
DEAFNESS, X-LINKED 3	0.0454545	0.831811379008378
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0454545	0.831811379008378
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.0454545	0.831811379008378
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.0454545	0.831811379008378
USHER SYNDROME, TYPE IC	0.0454545	0.831811379008378
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.0454545	0.831811379008378
USHER SYNDROME, TYPE IE; USH1E	0.0454545	0.831811379008378
USHER SYNDROME, TYPE IIC	0.0454545	0.831811379008378
USHER SYNDROME, TYPE IIA	0.0454545	0.831811379008378
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.0454545	0.831811379008378
ANGIOMA, HEREDITARY NEUROCUTANEOUSSPINAL ARTERIAL VENOUS MALFORMATIONS WITH CUTANEOUS HEMANGIOMAS, INCLUDED	0.0454545	0.831811379008378
PERRAULT SYNDROME 3	0.0454545	0.831811379008378
OMODYSPLASIA 1; OMOD1	0.0454545	0.831811379008378
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.0454545	0.831811379008378
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.0454545	0.831811379008378
USHER SYNDROME, TYPE IF	0.0454545	0.831811379008378
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.0454545	0.831811379008378
#214700 DIARRHEA 1, SECRETORY CHLORIDE, CONGENITAL; DIAR1;;CHLORIDE DIARRHEA, CONGENITAL, FINNISH TYPE;;CHLORIDORRHEA, CONGENITAL	0.045408199999999996	0.830964095090436
MAPLE SYRUP URINE DISEASE; MSUD	0.045404280000000005	0.8308923596053751
3MC SYNDROME 2	0.044586242	0.8159223716644394
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.04453524	0.8149890417641614
COHEN-GIBSON SYNDROME; COGIS	0.044467071999999996	0.8137415763188426
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.04445999999999999	0.8136121596478342
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.04445999999999999	0.8136121596478342
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.044322182	0.8110901083518751
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.044232971999999995	0.8094575770706743
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.04421123	0.8090597013267458
#602588 BRANCHIOOTIC SYNDROME 1; BOS1;;BO SYNDROME 1;;BRANCHIOOTIC DYSPLASIAANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED	0.04421123	0.8090597013267458
FOCAL DERMAL HYPOPLASIA; FDH	0.044154259999999994	0.8080171578104358
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.043493590000000006	0.7959269835973337
#300853 IMMUNODEFICIENCY, X-LINKED, WITH MAGNESIUM DEFECT, EPSTEIN-BARR VIRUSINFECTION, AND NEOPLASIA; XMEN	0.043478300000000004	0.7956471786058578
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.043478300000000004	0.7956471786058578
MEESTER-LOEYS SYNDROME; MRLS	0.043478300000000004	0.7956471786058578
LYMPHOPROLIFERATIVE SYNDROME, X-LINKED, 1; XLP1	0.043478300000000004	0.7956471786058578
LYMPHOMA, NON-HODGKIN, FAMILIAL	0.043478300000000004	0.7956471786058578
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.043478300000000004	0.7956471786058578
#604308 MASS SYNDROME;;MASS PHENOTYPE;;OVERLAP CONNECTIVE TISSUE DISEASE; OCTD	0.043478300000000004	0.7956471786058578
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.043478300000000004	0.7956471786058578
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.043478300000000004	0.7956471786058578
FOLLICULAR LYMPHOMA	0.043478300000000004	0.7956471786058578
NOONAN SYNDROME 8; NS8	0.043478300000000004	0.7956471786058578
NOONAN SYNDROME 10; NS10	0.043478300000000004	0.7956471786058578
THREE M SYNDROME 2; 3M2	0.043478300000000004	0.7956471786058578
#611554 LEOPARD SYNDROME 2	0.043478300000000004	0.7956471786058578
#613011 LYMPHOPROLIFERATIVE SYNDROME 1; LPFS1	0.043478300000000004	0.7956471786058578
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.043331442	0.7929596964974105
FLYNN-AIRD SYNDROME	0.04293771	0.7857544526188127
ELSAHY-WATERS SYNDROME; ESWS	0.042928572	0.785587228419198
RAINE SYNDROME	0.04251058199999999	0.7779380663271783
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.04251058199999999	0.7779380663271783
LIG4 SYNDROME	0.04251058199999999	0.7779380663271783
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.04251058199999999	0.7779380663271783
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.04251058199999999	0.7779380663271783
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.04248756	0.7775167667513931
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.04248756	0.7775167667513931
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.041666699999999994	0.7624951365811609
CHARGE SYNDROME	0.041666699999999994	0.7624951365811609
OTOSCLEROSIS 4	0.041666699999999994	0.7624951365811609
#612290 MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATEMICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, INCLUDED	0.041666699999999994	0.7624951365811609
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	0.041666699999999994	0.7624951365811609
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.041666699999999994	0.7624951365811609
#614286 MYELODYSPLASTIC SYNDROME; MDS;;MYELODYSPLASTIC SYNDROME, SUSCEPTIBILITY TO, INCLUDED	0.041666699999999994	0.7624951365811609
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.041666699999999994	0.7624951365811609
#300448 ALPHA-THALASSEMIA MYELODYSPLASIA SYNDROME; ATMDS;;HEMOGLOBIN H DISEASE, ACQUIRED	0.041666699999999994	0.7624951365811609
#200600 ACHONDROGENESIS, TYPE IA; ACG1A;;ACHONDROGENESIS, HOUSTON-HARRIS TYPE	0.041666699999999994	0.7624951365811609
NEUTROPHILIA, HEREDITARY	0.041666699999999994	0.7624951365811609
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.041666699999999994	0.7624951365811609
IMMUNODEFICIENCY WITH HYPER-IGM, TYPE 4	0.041666699999999994	0.7624951365811609
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.041666699999999994	0.7624951365811609
CHROMOSOME 5Q DELETION SYNDROME	0.041666699999999994	0.7624951365811609
SPONDYLOCOSTAL DYSOSTOSIS 2, AUTOSOMAL RECESSIVE; SCDO2	0.041666699999999994	0.7624951365811609
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.041666699999999994	0.7624951365811609
OTOFACIOCERVICAL SYNDROME 2	0.041666699999999994	0.7624951365811609
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.041666699999999994	0.7624951365811609
#300676 MENTAL RETARDATION, X-LINKED, SYNDROMIC 14; MRXS14	0.041066990000000005	0.7515205223602344
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.04094906	0.7493624188517487
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.040843882	0.7474376752681355
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.040843882	0.7474376752681355
DEAFNESS, X-LINKED 2	0.04059579	0.7428976242579837
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.04	0.7319947455221182
DERMATOLEUKODYSTROPHY	0.04	0.7319947455221182
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.04	0.7319947455221182
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.04	0.7319947455221182
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.04	0.7319947455221182
Lipodystrophy, congenital generalized, type 2	0.04	0.7319947455221182
Lipodystrophy, congenital generalized, type 1	0.04	0.7319947455221182
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.03931452	0.7194505515681056
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.039305382	0.7192833273684911
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.039305382	0.7192833273684911
THUMBS, CONGENITAL CLASPED	0.0384757	0.7041002557571341
NEPHROTIC SYNDROME, TYPE 4	0.0384615	0.7038403976224736
BONE MINERAL DENSITY QUANTITATIVE TRAIT LOCUS 1	0.0384615	0.7038403976224736
ULNA METAPHYSEAL DYSPLASIA SYNDROME	0.0384615	0.7038403976224736
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.0384615	0.7038403976224736
WILMS TUMOR 5	0.0384615	0.7038403976224736
WILMS TUMOR 1	0.0384615	0.7038403976224736
BRACHYDACTYLY, TYPE A6	0.0384615	0.7038403976224736
OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT OF SPINE; OPLL	0.0384615	0.7038403976224736
CERVICAL VERTEBRAL BRIDGE	0.0384615	0.7038403976224736
CALCIFICATION OF JOINTS AND ARTERIES; CALJA	0.0384615	0.7038403976224736
CHROMOSOME 8q22.1 DUPLICATION SYNDROME	0.0384615	0.7038403976224736
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.0384615	0.7038403976224736
SPINAL INTRADURAL ARACHNOID CYSTS	0.0384615	0.7038403976224736
WILMS TUMOR 3	0.0384615	0.7038403976224736
WILMS TUMOR 6	0.0384615	0.7038403976224736
MULTIPLE TUMOR-ASSOCIATED CHROMOSOME REGION 1	0.0384615	0.7038403976224736
#250460 METAPHYSEAL DYSPLASIA WITHOUT HYPOTRICHOSIS;;CARTILAGE-HAIR HYPOPLASIA-LIKE SKELETAL DYSPLASIA WITHOUT HYPOTRICHOSISOR IMMUNODEFICIENCY;;CARTILAGE-HAIR HYPOPLASIA VARIANT, SKELETAL MANIFESTATIONS ONLY; CHHV	0.0384615	0.7038403976224736
WILMS TUMOR 4	0.0384615	0.7038403976224736
GAUCHER DISEASE, PERINATAL LETHAL	0.03804726	0.6962598600378466
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.037701609999999997	0.6899345104431035
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.03766649	0.6892918190565351
WITTEVEEN-KOLK SYNDROME	0.037374741999999996	0.6839528689811205
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.03705976	0.6781887397577693
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.03585782	0.6561933956469479
MARFANOID HYPERMOBILITY SYNDROME	0.03461538	0.6334569068562855
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0340433	0.6229879180058281
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.0340433	0.6229879180058281
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.0340433	0.6229879180058281
BLAU SYNDROME	0.033926189999999995	0.6208448203896256
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.03379453	0.6184354596847398
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.03379453	0.6184354596847398
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.03379453	0.6184354596847398
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.03379453	0.6184354596847398
COFFIN-LOWRY SYNDROME; CLS	0.03376302	0.6178588308239547
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.03373756	0.6173929161684297
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.03373756	0.6173929161684297
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0331536	0.6067065248785524
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0328314	0.6008103072033717
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.032093882	0.5873138246851721
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.032093882	0.5873138246851721
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.03169601	0.5800328193504127
PALLISTER-KILLIAN SYNDROME	0.03125427	0.5719490353782393
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.03125	0.5718708949391549
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.03125	0.5718708949391549
#600630 UV-SENSITIVE SYNDROME 1; UVSS1	0.03125	0.5718708949391549
ACHONDROPLASIA, SO-CALLED, AND SEVERE COMBINED IMMUNODEFICIENCY	0.03125	0.5718708949391549
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.03125	0.5718708949391549
DEAFNESS, AUTOSOMAL DOMINANT 70	0.03125	0.5718708949391549
%164900 OPHTHALMOMANDIBULOMELIC DYSPLASIA;;OMM SYNDROME	0.03125	0.5718708949391549
BREAST, UNILATERAL GIANT	0.03125	0.5718708949391549
PYLE DISEASE; PYL	0.03125	0.5718708949391549
#243700 HYPER-IgE RECURRENT INFECTION SYNDROME, AUTOSOMAL RECESSIVE;;HYPER-IgE SYNDROME, AUTOSOMAL RECESSIVE;;HIES, AUTOSOMAL RECESSIVE	0.03125	0.5718708949391549
#253310 LETHAL CONGENITAL CONTRACTURE SYNDROME 1; LCCS1;;LCCS;;MULTIPLE CONTRACTURE SYNDROME, FINNISH TYPE	0.03125	0.5718708949391549
USHER SYNDROME, TYPE IV; USH4	0.03125	0.5718708949391549
HERNIA, HIATUS	0.03125	0.5718708949391549
#615348 NEMALINE MYOPATHY 8; NEM8	0.03125	0.5718708949391549
ONCOCYTOMA	0.03125	0.5718708949391549
HURIEZ SYNDROME; HRZ	0.03125	0.5718708949391549
PYCNODYSOSTOSIS	0.03125	0.5718708949391549
ICHTHYOSIS, X-LINKED	0.03125	0.5718708949391549
SERTOLI CELL-ONLY SYNDROME	0.03125	0.5718708949391549
FASCIAL DYSTROPHY, CONGENITAL	0.03125	0.5718708949391549
MULTIPLE SELF-HEALING SQUAMOUS EPITHELIOMA	0.03125	0.5718708949391549
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.03125	0.5718708949391549
#603956 CERVICAL CANCER	0.03125	0.5718708949391549
PAGET DISEASE, EXTRAMAMMARY	0.03125	0.5718708949391549
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.03125	0.5718708949391549
CANCER, FAMILIAL, WITH IN VITRO RADIORESISTANCE	0.03125	0.5718708949391549
FIBROSCLEROSIS, MULTIFOCAL	0.03125	0.5718708949391549
#601518 PROSTATE CANCER, HEREDITARY, 1; HPC1;;PRCA1	0.03125	0.5718708949391549
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.03125	0.5718708949391549
NASOPHARYNGEAL CARCINOMA	0.03125	0.5718708949391549
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.03125	0.5718708949391549
SCALP-EAR-NIPPLE SYNDROME; SENS	0.03125	0.5718708949391549
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.03125	0.5718708949391549
#615540 DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76	0.03125	0.5718708949391549
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.03125	0.5718708949391549
NIPPLES, SUPERNUMERARY	0.03125	0.5718708949391549
TIBIA, ABSENCE OR HYPOPLASIA OF, WITH POLYDACTYLY, RETROCEREBELLAR ARACHNOID CYST, AND OTHER ANOMALIES	0.03125	0.5718708949391549
GALACTORRHEA	0.03125	0.5718708949391549
#613285 DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25	0.03125	0.5718708949391549
DRUG METABOLISM, POOR, CYP2D6-RELATEDDRUG METABOLISM, ULTRARAPID, CYP2D6-RELATED, INCLUDED	0.03125	0.5718708949391549
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.03125	0.5718708949391549
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03125	0.5718708949391549
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.03125	0.5718708949391549
ADAMANTINOMA OF LONG BONES	0.03125	0.5718708949391549
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.03125	0.5718708949391549
CINCA SYNDROME; CINCA	0.03125	0.5718708949391549
BROOKE-SPIEGLER SYNDROME; BSS	0.03125	0.5718708949391549
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.031146881999999997	0.569983849084936
ROSSELLI-GULIENETTI SYNDROME	0.031146881999999997	0.569983849084936
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.031146881999999997	0.569983849084936
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.031080782	0.5687742277679607
EAR WITHOUT HELIX	0.030302999999999997	0.5545409193389186
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.030302999999999997	0.5545409193389186
MUSICAL PERFECT PITCH	0.030302999999999997	0.5545409193389186
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.030302999999999997	0.5545409193389186
EAR ANTITRAGUS, TAG AT BASE OF	0.030302999999999997	0.5545409193389186
OTOONYCHOPERONEAL SYNDROME	0.030302999999999997	0.5545409193389186
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.030302999999999997	0.5545409193389186
DARWINIAN POINT OF PINNA	0.030302999999999997	0.5545409193389186
EXCHONDROSIS OF PINNA, POSTERIOR	0.030302999999999997	0.5545409193389186
HAIRY EARS, Y-LINKED	0.030302999999999997	0.5545409193389186
#192500 LONG QT SYNDROME 1; LQT1;;WARD-ROMANO SYNDROME; WRS;;ROMANO-WARD SYNDROME; RWS;;VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVALLONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED	0.030302999999999997	0.5545409193389186
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.030302999999999997	0.5545409193389186
EAR FOLDING	0.030302999999999997	0.5545409193389186
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.030302999999999997	0.5545409193389186
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.030302999999999997	0.5545409193389186
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.030302999999999997	0.5545409193389186
OSSIFIED EAR CARTILAGES	0.030302999999999997	0.5545409193389186
EAR MALFORMATION	0.030302999999999997	0.5545409193389186
DARWINIAN TUBERCLE OF PINNA	0.030302999999999997	0.5545409193389186
AREDYLD	0.030302999999999997	0.5545409193389186
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.03028086	0.5541357602472721
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.029753989999999998	0.5444941084579411
KAGAMI-OGATA SYNDROME	0.029316601999999997	0.5364899655140805
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.028827572000000003	0.5275407807540134
CORNELIA DE LANGE SYNDROME 1	0.02866358	0.5245397486963219
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.028498462	0.5215181109865438
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.028498462	0.5215181109865438
RESTRICTIVE DERMOPATHY, LETHAL	0.02847272	0.5210470357680631
SHPRINTZEN OMPHALOCELE SYNDROME	0.02835987	0.5189818955922588
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.02821369	0.5163068207947482
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.028008842	0.5125581293039803
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.0277933	0.5086137390179972
OSTEOGENESIS IMPERFECTA, TYPE I	0.0277933	0.5086137390179972
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.0277933	0.5086137390179972
KEUTEL SYNDROME; KTLS	0.0277933	0.5086137390179972
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.02754453	0.5040612806969088
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.02754453	0.5040612806969088
MCDONOUGH SYNDROME	0.02692422	0.49270968918203806
YUNIS-VARON SYNDROME	0.026824689999999998	0.4908883032564927
MEGAEPIPHYSEAL DWARFISM	0.026364560000000002	0.48246798470006536
NEPHROSIALIDOSIS	0.026364560000000002	0.48246798470006536
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.026280252	0.48092515937492847
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.025843882000000002	0.47293964569734126
CYCLIC VOMITING SYNDROME	0.025685140000000002	0.4700346879499995
ENDOCARDIAL FIBROELASTOSIS	0.02562466	0.46892791189477
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.025341172	0.4637401187343056
COFFIN-SIRIS SYNDROME 6; CSS6	0.025010952	0.4576971361126478
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.025	0.45749671595132385
COMBINED INFLAMMATORY AND IMMUNOLOGIC DEFECT	0.025	0.45749671595132385
HOOFT DISEASE	0.025	0.45749671595132385
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.025	0.45749671595132385
202155 ADRENAL HYPOPLASIA, CYTOMEGALIC TYPE	0.025	0.45749671595132385
#219900 CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE;;CYSTINOSIS, INTERMEDIATE	0.025	0.45749671595132385
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.025	0.45749671595132385
GROWTH CONTROL, Y-CHROMOSOME INFLUENCED	0.025	0.45749671595132385
MUCOPOLYSACCHARIDOSES, UNCLASSIFIED TYPES	0.025	0.45749671595132385
248110 MACROSOMIA WITH MICROPHTHALMIA, LETHAL	0.025	0.45749671595132385
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.025	0.45749671595132385
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.025	0.45749671595132385
LATERALITY DEFECTS, AUTOSOMAL DOMINANT	0.025	0.45749671595132385
274210 THYMIC APLASIA WITH FETAL DEATH	0.025	0.45749671595132385
EPIPHYSEAL DYSPLASIA, BAUMANN TYPE	0.025	0.45749671595132385
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.024875271999999997	0.4552142099358367
MENTAL RETARDATION, X-LINKED 102	0.024701559999999997	0.45203530315498325
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.024373902	0.4460392047967761
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.024059902	0.4402930460444276
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.024045381999999997	0.440027331951803
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.023792692	0.43540313814565346
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.023792692	0.43540313814565346
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.023739642	0.4344323301144047
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.023735722	0.43436059462934357
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.023735722	0.43436059462934357
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.023631489999999998	0.4324531627214619
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.023216019999999997	0.42485011629841013
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.023216019999999997	0.42485011629841013
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.023197580000000002	0.42451266672072446
MOWAT-WILSON SYNDROME; MOWS	0.02297251	0.4203939152863579
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.022952729999999998	0.4200319438846971
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.022952729999999998	0.4200319438846971
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.022752141999999996	0.41636120983432734
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.022752141999999996	0.41636120983432734
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.02271199	0.4156264335087723
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.022411872	0.41013431353285706
PETERS-PLUS SYNDROME; PTRPLS	0.022411871999999996	0.41013431353285706
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0224011	0.40993718734788803
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.022292612	0.4079518711990829
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.02215233	0.4053847290267997
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.022066302000000003	0.40381042792760524
STICKLER SYNDROME, TYPE I	0.021965119999999998	0.40195881061906963
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0216612	0.3963971145425926
SPONDYLOOCULAR SYNDROME; SOS	0.02131922	0.3901389254657513
MARFAN SYNDROME; MFS	0.02130309	0.3898437485846195
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.02130309	0.3898437485846195
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.021298632	0.3897621677702311
#300867 KABUKI SYNDROME 2; KABUK2	0.021276242	0.3893524337114251
MEIER-GORLIN SYNDROME 7	0.021276242	0.3893524337114251
Pierpont syndrome	0.021276242	0.3893524337114251
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.021252082	0.3889103088851297
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.021252082	0.3889103088851297
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.021252082	0.3889103088851297
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.021252082	0.3889103088851297
TYSHCHENKO SYNDROME	0.021252082	0.3889103088851297
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.021252082	0.3889103088851297
ROIFMAN SYNDROME; RFMN	0.021252082	0.3889103088851297
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.021252082	0.3889103088851297
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.021248162	0.38883857340006855
CITRULLINEMIA, CLASSIC	0.021248162	0.38883857340006855
METHYLMALONIC ACIDURIA, CBLB TYPE	0.021248162	0.38883857340006855
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.021248162	0.38883857340006855
ARGININOSUCCINIC ACIDURIA	0.021248162	0.38883857340006855
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.021248162	0.38883857340006855
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.021248162	0.38883857340006855
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.021248162	0.38883857340006855
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.021248162	0.38883857340006855
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.021248162	0.38883857340006855
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.021248162	0.38883857340006855
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.021248162	0.38883857340006855
PROPIONIC ACIDEMIA	0.021248162	0.38883857340006855
METHYLMALONIC ACIDURIA, CBLA TYPE	0.021248162	0.38883857340006855
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.02104246	0.3850742538214837
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.02104246	0.3850742538214837
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.021027472	0.3847999753903366
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.020758541999999998	0.37987859171750504
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0204732	0.3746568706005858
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.020451682000000002	0.3742630940272322
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020451682000000002	0.3742630940272322
BAND HETEROTOPIA; BH	0.020451682000000002	0.3742630940272322
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.020408199999999998	0.3734673791391122
TEMPLE SYNDROME	0.020408199999999998	0.3734673791391122
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.020408199999999998	0.3734673791391122
ATELOSTEOGENESIS, TYPE I; AO1	0.020408199999999998	0.3734673791391122
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.020408199999999998	0.3734673791391122
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.020408199999999998	0.3734673791391122
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.020408199999999998	0.3734673791391122
#609152 HYPERTHYROIDISM, NONAUTOIMMUNE;;HYPERTHYROIDISM, CONGENITAL NONAUTOIMMUNE;;HYPERTHYROIDISM, NONAUTOIMMUNE, AUTOSOMAL DOMINANT;;TOXIC THYROID HYPERPLASIA, AUTOSOMAL DOMINANT	0.020408199999999998	0.3734673791391122
#215045 CHONDRODYSPLASIA, BLOMSTRAND TYPE; BOCD	0.020408199999999998	0.3734673791391122
KNIEST-LIKE DYSPLASIA, LETHAL	0.020408199999999998	0.3734673791391122
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.020408199999999998	0.3734673791391122
#267450 RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS;;RDS OF PREMATURITY;;HYALINE MEMBRANE DISEASE, FORMERLY	0.020408199999999998	0.3734673791391122
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.020408199999999998	0.3734673791391122
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.020408199999999998	0.3734673791391122
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.020408199999999998	0.3734673791391122
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.020408199999999998	0.3734673791391122
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.020408199999999998	0.3734673791391122
NEMALINE MYOPATHY 10	0.020408199999999998	0.3734673791391122
CORNEODERMATOOSSEOUS SYNDROME	0.020408199999999998	0.3734673791391122
#242500 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4B; ARCI4B;;ICHTHYOSIS CONGENITA, HARLEQUIN FETUS TYPE;;HARLEQUIN ICHTHYOSIS; HI;;'HARLEQUIN FETUS'	0.020408199999999998	0.3734673791391122
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.020408199999999998	0.3734673791391122
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.02040428	0.37339564365405115
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.02040428	0.37339564365405115
#229600 FRUCTOSE INTOLERANCE, HEREDITARY;;FRUCTOSEMIA;;FRUCTOSE-1-PHOSPHATE ALDOLASE DEFICIENCY;;FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE B DEFICIENCY;;ALDOLASE B DEFICIENCY;;ALDOB DEFICIENCY	0.02040428	0.37339564365405115
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.02040428	0.37339564365405115
INFANTILE LIVER FAILURE SYNDROME 2	0.02040428	0.37339564365405115
#275350 TRANSCOBALAMIN II DEFICIENCY;;TC II DEFICIENCY;;TCN2 DEFICIENCY	0.02040428	0.37339564365405115
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.02040428	0.37339564365405115
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.020167459999999998	0.36906186876318736
JOUBERT SYNDROME 21	0.020161672000000002	0.36895594912351043
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.020161672000000002	0.36895594912351043
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.01991466	0.36443566197148763
#222748 DIHYDROPYRIMIDINASE DEFICIENCY;;DIHYDROPYRIMIDINURIA;;DPYS DEFICIENCY;;DPH DEFICIENCY	0.01991466	0.36443566197148763
BARATELA-SCOTT SYNDROME	0.019805052	0.3624298499698079
MEVALONIC ACIDURIA; MEVA	0.019777972	0.3619342895270895
KNUCKLE PADS	0.0196078	0.3588201642812147
CARPAL DISPLACEMENT	0.0196078	0.3588201642812147
MONOPHALANGY OF GREAT TOE	0.0196078	0.3588201642812147
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	0.3588201642812147
PACHYDERMODACTYLY, FAMILIAL	0.0196078	0.3588201642812147
PUBIC BONE DYSPLASIA	0.0196078	0.3588201642812147
BEEMER LETHAL MALFORMATION SYNDROME	0.0196078	0.3588201642812147
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	0.3588201642812147
DOUBLE NAIL FOR FIFTH TOE	0.0196078	0.3588201642812147
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	0.3588201642812147
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	0.3588201642812147
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	0.3588201642812147
VESICOURETERAL REFLUX 1	0.0196078	0.3588201642812147
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	0.3588201642812147
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	0.3588201642812147
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	0.3588201642812147
RAYNAUD DISEASE	0.0196078	0.3588201642812147
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	0.3588201642812147
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	0.3588201642812147
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	0.3588201642812147
TRACHEOBRONCHOMEGALY	0.0196078	0.3588201642812147
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	0.3588201642812147
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	0.3588201642812147
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	0.3588201642812147
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	0.3588201642812147
LETTERER-SIWE DISEASE	0.0196078	0.3588201642812147
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	0.3588201642812147
THALIDOMIDE SUSCEPTIBILITY	0.0196078	0.3588201642812147
SPINAL ARACHNOIDITIS	0.0196078	0.3588201642812147
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	0.3588201642812147
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	0.3588201642812147
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	0.3588201642812147
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	0.3588201642812147
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	0.3588201642812147
VAN DEN BOSCH SYNDROME	0.0196078	0.3588201642812147
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	0.3588201642812147
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	0.3588201642812147
HHHH SYNDROME	0.0196078	0.3588201642812147
THROMBOCYTOPENIA 3	0.0196078	0.3588201642812147
TOE, MISSHAPEN	0.0196078	0.3588201642812147
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0188679	0.3452800914759193
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0188679	0.3452800914759193
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0188679	0.3452800914759193
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0188679	0.3452800914759193
COGNITIVE FUNCTION 1, SOCIAL	0.0188679	0.3452800914759193
MYOPATHY, CONGENITAL	0.0188679	0.3452800914759193
JUMPING FRENCHMAN OF MAINE	0.0188679	0.3452800914759193
CERVICAL RIB	0.0188679	0.3452800914759193
#220100 CYSTINURIA;;CSNU;;CYSTINURIA, TYPE I, FORMERLY; CSNU1, FORMERLY;;CYSTINURIA, TYPE II, FORMERLY;;CYSTINURIA, TYPE III, FORMERLY; CSNU3, FORMERLY;;CYSTINURIA, TYPE NON-I, FORMERLYCYSTINURIA, TYPE A, INCLUDED;;CYSTINURIA, TYPE B, INCLUDED;;CYSTINURIA, TYPE A/B, INCLUDED	0.0188679	0.3452800914759193
MOTION SICKNESS	0.0188679	0.3452800914759193
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0188679	0.3452800914759193
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0188679	0.3452800914759193
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0188679	0.3452800914759193
ALCOHOL DEPENDENCE	0.0188679	0.3452800914759193
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0188679	0.3452800914759193
#601277 ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 4A; ARCI4A;;ICHTHYOSIS CONGENITA IIB; ICR2B;;ICHTHYOSIS, LAMELLAR, 2, FORMERLY; LI2, FORMERLY	0.0188679	0.3452800914759193
NOVELTY SEEKING PERSONALITY TRAIT	0.0188679	0.3452800914759193
TRANSSEXUALITY	0.0188679	0.3452800914759193
PALMOMENTAL REFLEX	0.0188679	0.3452800914759193
269800 SENILE PLAQUE FORMATION	0.0188679	0.3452800914759193
SPASTIC PSEUDOSCLEROSIS	0.0188679	0.3452800914759193
PERONEAL NERVE, ACCESSORY DEEP	0.0188679	0.3452800914759193
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0188679	0.3452800914759193
DIASTEMATOMYELIA	0.0188679	0.3452800914759193
GRANULOMAS, CONGENITAL CEREBRAL	0.0188679	0.3452800914759193
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0188679	0.3452800914759193
CARDIAC ARRHYTHMIA	0.0188679	0.3452800914759193
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0188679	0.3452800914759193
141405 HEMIFACIAL SPASM, FAMILIAL	0.0188679	0.3452800914759193
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0188679	0.3452800914759193
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0188679	0.3452800914759193
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0188679	0.3452800914759193
RHEUMATOID ARTHRITIS	0.0188679	0.3452800914759193
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0188679	0.3452800914759193
SPATIAL VISUALIZATION, APTITUDE FOR	0.0188679	0.3452800914759193
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0188679	0.3452800914759193
ERYTHERMALGIA, PRIMARY	0.0188679	0.3452800914759193
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0188679	0.3452800914759193
#610189 SENIOR-LOKEN SYNDROME 6; SLSN6	0.0188679	0.3452800914759193
ANDROSTENONE, ABILITY TO SMELL	0.0188679	0.3452800914759193
MERALGIA PARAESTHETICA, FAMILIAL	0.0188679	0.3452800914759193
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0188679	0.3452800914759193
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0188679	0.3452800914759193
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0188679	0.3452800914759193
CHROMOSOME 1P36 DELETION SYNDROME	0.018844952	0.3448601460904133
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.018788682	0.34383041248215007
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.018788682	0.34383041248215007
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.018788682	0.34383041248215007
SPONDYLOPERIPHERAL DYSPLASIA	0.01861152	0.3405883711544953
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.01855455	0.3395458276381854
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.018539912	0.3392779541610616
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.018523782000000003	0.33898277727992987
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.018482942	0.3382354106447517
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.018482942	0.3382354106447517
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.018482942	0.3382354106447517
LARSEN-LIKE SYNDROME	0.018254192	0.33404931569379714
MARSHALL-SMITH SYNDROME; MRSHSS	0.017944799999999997	0.32838748273613255
Orofaciodigital syndrome XVII	0.017944799999999997	0.32838748273613255
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.017922882	0.32798638621532383
BARDET-BIEDL SYNDROME 16; BBS16	0.017922882	0.32798638621532383
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.01785543	0.32675202347594984
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.017696029999999998	0.3238350244150442
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.017696029999999998	0.3238350244150442
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.0176799	0.3235398475339124
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.0176799	0.3235398475339124
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.0176799	0.3235398475339124
LOEYS-DIETZ SYNDROME 5	0.0176799	0.3235398475339124
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.0176799	0.3235398475339124
JABERI-ELAHI SYNDROME; JABELS	0.017675442	0.323458266719524
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.017674112000000002	0.3234339278942354
#231000 GAUCHER DISEASE, TYPE III;;GD III;;GAUCHER DISEASE, SUBACUTE NEURONOPATHIC TYPE;;GAUCHER DISEASE, CHRONIC NEURONOPATHIC TYPE;;GAUCHER DISEASE, JUVENILE AND ADULT, CEREBRALGAUCHER DISEASE, TYPE IIIA, INCLUDED;;GAUCHER DISEASE, TYPE IIIB, INCLUDED;;GAUCHER DISEASE, NORRBOTTNIAN TYPE, INCLUDED	0.017639059999999998	0.3227924808987343
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.017617142000000002	0.3223913843779255
JOUBERT SYNDROME 14	0.017617142000000002	0.3223913843779255
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.01741031	0.3186063859477797
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.016910872	0.30946673615492787
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.016910872	0.30946673615492787
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.01678109	0.307091742603344
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.016539812	0.30267638689809195
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.01637214	0.29960801132381226
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.01637214	0.29960801132381226
CODAS SYNDROME	0.016357392	0.29933812486113826
#259450 BRUCK SYNDROME 1; BRKS1	0.01606699	0.2940238064089104
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.01606699	0.2940238064089104
Osteogenesis imperfecta, type IX	0.01606699	0.2940238064089104
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.01606699	0.2940238064089104
MARFANOID HABITUS WITH SITUS INVERSUS	0.01606699	0.2940238064089104
AL KAISSI SYNDROME; ALKAS	0.015995382	0.29271338941547675
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.015995382	0.29271338941547675
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.015995382	0.29271338941547675
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.015995382	0.29271338941547675
ALAZAMI SYNDROME; ALAZS	0.015995382	0.29271338941547675
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.015995382	0.29271338941547675
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.015995382	0.29271338941547675
N-ACETYLASPARTATE DEFICIENCY; NACED	0.015995382	0.29271338941547675
FORSYTHE-WAKELING SYNDROME; FWS	0.015995382	0.29271338941547675
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.015995382	0.29271338941547675
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.015995382	0.29271338941547675
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.015995382	0.29271338941547675
LATERAL MENINGOCELE SYNDROME	0.0157974	0.28909034482277773
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.015665162	0.2866704067938189
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.015665162	0.2866704067938189
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.015665162	0.2866704067938189
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.015324892000000001	0.2804435104923486
GRANGE SYNDROME; GRNG	0.015151499999999998	0.2772704596694593
FG SYNDROME 2; FGS2	0.015151499999999998	0.2772704596694593
SECKEL SYNDROME 4	0.015151499999999998	0.2772704596694593
MEIER-GORLIN SYNDROME 8; MGORS8	0.015151499999999998	0.2772704596694593
FILIPPI SYNDROME; FLPIS	0.015151499999999998	0.2772704596694593
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.015151499999999998	0.2772704596694593
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.015151499999999998	0.2772704596694593
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.015151499999999998	0.2772704596694593
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION, X-LINKED; CFTDX	0.015151499999999998	0.2772704596694593
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.015151499999999998	0.2772704596694593
#616311 MENTAL RETARDATION, AUTOSOMAL DOMINANT 33; MRD33	0.015151499999999998	0.2772704596694593
OVARIAN DYSGENESIS 4; ODG4	0.015151499999999998	0.2772704596694593
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.015151499999999998	0.2772704596694593
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.015151499999999998	0.2772704596694593
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.015151499999999998	0.2772704596694593
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.015151499999999998	0.2772704596694593
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.015129582	0.2768693631486505
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.015129582	0.2768693631486505
JOUBERT SYNDROME 2	0.015129582	0.2768693631486505
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.015129582	0.2768693631486505
JOUBERT SYNDROME 7	0.015129582	0.2768693631486505
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.015129582	0.2768693631486505
#614970 JOUBERT SYNDROME 20; JBTS20	0.015129582	0.2768693631486505
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.015129582	0.2768693631486505
JOUBERT SYNDROME 1	0.015129582	0.2768693631486505
BARDET-BIEDL SYNDROME 17; BBS17	0.015129582	0.2768693631486505
Retinitis pigmentosa with or without skeletal anomalies	0.015129582	0.2768693631486505
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.015106890000000001	0.2764541025295158
COCKAYNE SYNDROME A; CSA	0.015106890000000001	0.2764541025295158
MEIER-GORLIN SYNDROME 1; MGORS1	0.01489624	0.27259923520090995
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.01482128	0.2712274770478014
HEMIFACIAL MICROSOMIA	0.01437788	0.2631133152936888
CHROMOSOME 18Q DELETION SYNDROME	0.01437788	0.2631133152936888
HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 4; HNFJ4	0.0142857	0.26142643340263305
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.0142857	0.26142643340263305
SHORT-RIB THORACIC DYSPLASIA 1 WITH OR WITHOUT POLYDACTYLY; SRTD1	0.0142857	0.26142643340263305
POLYCYSTIC LIVER DISEASE 3 WITH OR WITHOUT KIDNEY CYSTS; PCLD3	0.0142857	0.26142643340263305
ALAGILLE SYNDROME 2	0.0142857	0.26142643340263305
MECKEL SYNDROME, TYPE 10; MKS10	0.0142857	0.26142643340263305
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.0142857	0.26142643340263305
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.0142857	0.26142643340263305
FRYNS SYNDROME; FRNS	0.0142857	0.26142643340263305
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.0142857	0.26142643340263305
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.0142857	0.26142643340263305
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.0142857	0.26142643340263305
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0142857	0.26142643340263305
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.0142857	0.26142643340263305
BARDET-BIEDL SYNDROME 10; BBS10	0.0142857	0.26142643340263305
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0142857	0.26142643340263305
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0142857	0.26142643340263305
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT 3; CAKUT3	0.0142857	0.26142643340263305
#614465 JOUBERT SYNDROME 16; JBTS16	0.0142857	0.26142643340263305
AXIAL OSTEOMALACIA	0.0142857	0.26142643340263305
POLYCYSTIC LIVER DISEASE 4 WITH OR WITHOUT KIDNEY CYSTS; PCLD4	0.0142857	0.26142643340263305
BARDET-BIEDL SYNDROME 4; BBS4	0.0142857	0.26142643340263305
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.0142857	0.26142643340263305
GENITOPALATOCARDIAC SYNDROME	0.0142857	0.26142643340263305
NEPHRONOPHTHISIS 20	0.0142857	0.26142643340263305
BARDET-BIEDL SYNDROME 6; BBS6	0.0142857	0.26142643340263305
MECKEL SYNDROME, TYPE 4; MKS4	0.0142857	0.26142643340263305
#603194 MECKEL SYNDROME, TYPE 2; MKS2;;MECKEL-GRUBER SYNDROME, TYPE 2	0.0142857	0.26142643340263305
ANGIOPATHY, HEREDITARY, WITH NEPHROPATHY, ANEURYSMS, AND MUSCLE CRAMPS	0.0142857	0.26142643340263305
MECKEL SYNDROME, TYPE 6; MKS6	0.0142857	0.26142643340263305
DYSTONIA, JUVENILE-ONSET	0.01423224	0.2604481224252428
INCONTINENTIA PIGMENTI; IP	0.01417527	0.2594055789089329
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.014082452	0.2577070217016861
SAUL-WILSON SYNDROME; SWILS	0.014082451999999999	0.2577070217016861
KLEEFSTRA SYNDROME 2; KLEFS2	0.014052252000000001	0.2571543656688169
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.014052252	0.2571543656688169
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.014052252	0.2571543656688169
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.01400314	0.25625562252026485
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.01400314	0.25625562252026485
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.01400314	0.25625562252026485
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.01400314	0.25625562252026485
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.01400314	0.25625562252026485
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.014001782	0.25623077129865435
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.014001782	0.25623077129865435
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.014001782	0.25623077129865435
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.014001782	0.25623077129865435
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.014001782	0.25623077129865435
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.014001782	0.25623077129865435
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.014001782	0.25623077129865435
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.014001782	0.25623077129865435
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.014001782	0.25623077129865435
GABA-TRANSAMINASE DEFICIENCY	0.014001782	0.25623077129865435
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.014001782	0.25623077129865435
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.014001782	0.25623077129865435
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.014001782	0.25623077129865435
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.014001782	0.25623077129865435
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.014001782	0.25623077129865435
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.013940492000000002	0.25510917234982816
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.013406241999999999	0.24533246752994828
KOOLEN-DE VRIES SYNDROME; KDVS	0.013406241999999999	0.24533246752994828
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.01340235	0.24526124444120903
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.01334538	0.24421870092489914
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.013252561999999999	0.2425201437176523
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.013252561999999999	0.2425201437176523
MARTSOLF SYNDROME	0.01323857	0.2422640919556687
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.0131579	0.24078784155263694
#613710 THIAMINE METABOLISM DYSFUNCTION SYNDROME 4 (BILATERAL STRIATAL DEGENERATIONAND PROGRESSIVE POLYNEUROPATHY TYPE); THMD4;;BILATERAL STRIATAL DEGENERATION AND PROGRESSIVE POLYNEUROPATHY;;STRIATAL NECROSIS, BILATERAL, AND PROGRESSIVE POLYNEUROPATHY	0.0131579	0.24078784155263694
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.0131579	0.24078784155263694
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0131579	0.24078784155263694
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.0131579	0.24078784155263694
VISCERAL STEATOSIS, CONGENITAL	0.0131579	0.24078784155263694
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.0131579	0.24078784155263694
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.0131579	0.24078784155263694
RENAL TUBULAR ACIDOSIS, DISTAL, WITH HEMOLYTIC ANEMIA	0.0131579	0.24078784155263694
PSEUDO-TORCH SYNDROME 2	0.0131579	0.24078784155263694
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.0131579	0.24078784155263694
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.0131579	0.24078784155263694
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0131579	0.24078784155263694
MYXEDEMA	0.0131579	0.24078784155263694
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.0131579	0.24078784155263694
ACRODERMATITIS ENTEROPATHICA, ZINC-DEFICIENCY TYPE	0.0131579	0.24078784155263694
HEMOCHROMATOSIS, TYPE 2A	0.0131579	0.24078784155263694
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.0131579	0.24078784155263694
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.0131579	0.24078784155263694
GLYCINE ENCEPHALOPATHY; GCE	0.0131579	0.24078784155263694
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.0131579	0.24078784155263694
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.0131579	0.24078784155263694
CIRRHOSIS, FAMILIAL	0.0131579	0.24078784155263694
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.013122352	0.24013731782229147
WILLIAMS-BEUREN SYNDROME; WBS	0.01309661	0.2396662426038107
#614976 CARPENTER SYNDROME 2; CRPT2	0.013003792	0.2379676853965639
LATHOSTEROLOSIS	0.01296898	0.237330630369536
KAPUR-TORIELLO SYNDROME	0.01296898	0.237330630369536
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.01296898	0.237330630369536
OCULODENTODIGITAL DYSPLASIA; ODDD	0.01296898	0.237330630369536
LAMB-SHAFFER SYNDROME	0.012946822	0.23692514188025401
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.012946822	0.23692514188025401
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.012881502000000001	0.23572979446081643
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.012881502	0.23572979446081638
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0128681	0.2354845396213292
IMMUNODEFICIENCY 23; IMD23	0.012734202	0.23303422381043118
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.012734202	0.23303422381043118
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.012677232	0.23199168029412132
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.012677232	0.23199168029412132
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.012632732	0.23117733613972796
EMANUEL SYNDROME	0.012576352	0.23014558954591458
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.012576352	0.23014558954591458
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.01256236	0.2298895377839309
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.01240868	0.2270772139716349
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.012327582	0.2255931312248261
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.01213909	0.22214375238550224
#300799 MENTAL RETARDATION, X-LINKED, SYNDROMIC, RAYMOND TYPE; MRXSR	0.01210294	0.22148221213423663
SCARF SYNDROME	0.01210294	0.22148221213423663
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01210294	0.22148221213423663
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01189032	0.2175912940644138
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.01189032	0.2175912940644138
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.01189032	0.2175912940644138
VAN MALDERGEM SYNDROME 2; VMLDS2	0.01189032	0.2175912940644138
VAN MALDERGEM SYNDROME 1; VMLDS1	0.01189032	0.2175912940644138
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.01189032	0.2175912940644138
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.01189032	0.2175912940644138
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.01189032	0.2175912940644138
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.01183335	0.2165487505481039
MEIER-GORLIN SYNDROME 6; MGORS6	0.01183335	0.2165487505481039
FLOATING-HARBOR SYNDROME	0.01183335	0.2165487505481039
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.01183335	0.2165487505481039
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.01178885	0.21573440639371055
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.011701702000000001	0.21413960944164154
YOU-HOOVER-FONG SYNDROME; YHFS	0.011701702000000001	0.21413960944164154
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.01168771	0.2138835576796579
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.0114837	0.2101502014788087
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.011452932	0.2095871511205531
RAHMAN SYNDROME	0.011395962	0.20854460760424323
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.011395962	0.20854460760424323
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.011223832	0.20539465121557515
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.011223832	0.20539465121557515
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.011223832	0.20539465121557515
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.011223832	0.20539465121557515
MEND SYNDROME; MEND	0.010918681999999999	0.1998104463006733
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.010883562000000001	0.19916775491410488
GALACTOSEMIA	0.01086957	0.19891170315212126
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.01086957	0.19891170315212126
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.01085782	0.19869667969562413
CAMPOMELIC DYSPLASIA	0.01085782	0.19869667969562413
MICROPHTHALMIA, SYNDROMIC 1	0.01085782	0.19869667969562413
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.01085782	0.19869667969562413
GALACTOSE EPIMERASE DEFICIENCY	0.010634792	0.19461529659301646
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.01060905	0.19414422137453569
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.01060905	0.19414422137453569
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.01060905	0.19414422137453569
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.01060905	0.19414422137453569
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.010577822	0.1935727530767066
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.010577822	0.1935727530767066
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010577822	0.1935727530767066
CHROMOSOME 19p13.13 DELETION SYNDROME	0.010577822	0.1935727530767066
MELNICK-NEEDLES SYNDROME	0.01055208	0.19310167785822582
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.010459262	0.19140312065097903
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.010459262	0.19140312065097903
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.010459262	0.19140312065097903
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.010459262	0.19140312065097903
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.010459262	0.19140312065097903
HAREL-YOON SYNDROME; HAYOS	0.010459262	0.19140312065097903
CATEL-MANZKE SYNDROME; CATMANS	0.010459262	0.19140312065097903
Glycosylphosphatidylinositol biosynthesis defect 18	0.010459262	0.19140312065097903
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.010459262	0.19140312065097903
DESBUQUOIS DYSPLASIA 2; DBQD2	0.010459262	0.19140312065097903
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.010459262	0.19140312065097903
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.010393942	0.1902077732315414
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.010393942	0.1902077732315414
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.010393942	0.1902077732315414
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.010393942	0.1902077732315414
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.010189672	0.1864696590648463
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.010145172000000001	0.18565531491045298
HURLER SYNDROME	0.010088792	0.1846235683166395
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.010088792	0.1846235683166395
CHROMOSOME 16p13.2 DELETION SYNDROME	0.010088202000000001	0.18461277139414312
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.010088202000000001	0.18461277139414312
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.010088202000000001	0.18461277139414312
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.010088202000000001	0.18461277139414312
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.010088202000000001	0.18461277139414312
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.010088202000000001	0.18461277139414312
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.010088202000000001	0.18461277139414312
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.010088202	0.18461277139414306
ASPARTYLGLUCOSAMINURIA; AGU	0.0100748	0.1843675165546559
KRABBE DISEASE	0.01003968	0.18372482516808747
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.01003968	0.18372482516808747
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.01003968	0.18372482516808747
CDAGS SYNDROME	0.009840022	0.18007110999555112
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00979091	0.17917236684699903
ZTTK SYNDROME; ZTTKS	0.009783052	0.17902856647924123
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.009783052	0.17902856647924123
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.009783052	0.17902856647924123
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.009783052	0.17902856647924123
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.009783052	0.17902856647924123
PELGER-HUET ANOMALY; PHA	0.009783052	0.17902856647924123
MARINESCO-SJOGREN SYNDROME; MSS	0.009783052	0.17902856647924123
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.009783052	0.17902856647924123
BARDET-BIEDL SYNDROME 1; BBS1	0.009747932	0.17838587509267284
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.009747932	0.17838587509267284
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00973394	0.17812982333068916
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.00961538	0.17596019090496162
#605355 NEMALINE MYOPATHY 5; NEM5;;NEMALINE MYOPATHY, AMISH TYPE; ANM;;AMISH NEMALINE MYOPATHY	0.00961538	0.17596019090496162
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.00961538	0.17596019090496162
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.00961538	0.17596019090496162
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00961538	0.17596019090496162
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.00961538	0.17596019090496162
BRUCK SYNDROME 2	0.00961538	0.17596019090496162
%609052 SPONDYLOMETAPHYSEAL DYSPLASIA, TYPE A4	0.00961538	0.17596019090496162
ODONTOCHONDRODYSPLASIA; ODCD	0.00961538	0.17596019090496162
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00961538	0.17596019090496162
#100100 PRUNE BELLY SYNDROME; PBS;;ABDOMINAL MUSCLES, ABSENCE OF, WITH URINARY TRACT ABNORMALITY ANDCRYPTORCHIDISM;;EAGLE-BARRETT SYNDROME; EGBRS	0.00961538	0.17596019090496162
OSTEOGENESIS IMPERFECTA, TYPE XIX; OI19	0.00961538	0.17596019090496162
#184250 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, STRUDWICK TYPE; SEMDSTWK;;SEMD, STRUDWICK TYPE;;SPONDYLOMETAEPIPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE;;SMED, STRUDWICK TYPE;;SMED, TYPE I;;STRUDWICK SYNDROME;;DAPPLED METAPHYSIS SYNDROME;;SPONDYLOMETAPHYSEAL DYSPLASIA; SMD;;SEMDC	0.00961538	0.17596019090496162
TEEBI-SHALTOUT SYNDROME; TBSH	0.00961538	0.17596019090496162
ARTERIAL TORTUOSITY SYNDROME	0.00961538	0.17596019090496162
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00961538	0.17596019090496162
SPONDYLOMETAPHYSEAL DYSPLASIA, CORNER FRACTURE TYPE; SMDCF	0.00961538	0.17596019090496162
ELLIS-VAN CREVELD SYNDROME	0.00961538	0.17596019090496162
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00961538	0.17596019090496162
ACROCAPITOFEMORAL DYSPLASIA; ACFD	0.00961538	0.17596019090496162
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.00961538	0.17596019090496162
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00961538	0.17596019090496162
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.00961538	0.17596019090496162
%605967 ACROPECTORAL SYNDROME; ACRPS;;ACRP SYNDROME;;SYNDACTYLY, PREAXIAL POLYDACTYLY, AND STERNAL DEFORMITY	0.00961538	0.17596019090496162
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.009550059999999999	0.17476484348552399
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.009550059999999999	0.17476484348552399
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00934579	0.1710267293188289
#607842 AURAL ATRESIA, CONGENITAL; CAA;;AURAL ATRESIA, CONGENITAL, WITH HYPOSMIA	0.00934579	0.1710267293188289
#185800 SYMPHALANGISM, PROXIMAL, 1A; SYM1A;;SYM1;;CUSHING SYMPHALANGISM;;HEREDITARY ABSENCE OF THE PROXIMAL INTERPHALANGEAL JOINTS	0.00934579	0.1710267293188289
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00934579	0.1710267293188289
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00934579	0.1710267293188289
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00934579	0.1710267293188289
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00934579	0.1710267293188289
#184460 STAPES ANKYLOSIS WITH BROAD THUMB AND TOES;;ANKYLOSIS OF STAPES, HYPEROPIA, BROAD THUMBS, BROAD FIRST TOES, ANDSYNDACTYLY;;TEUNISSEN-CREMERS SYNDROME;;STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM	0.00934579	0.1710267293188289
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.00934579	0.1710267293188289
AGNATHIA-OTOCEPHALY COMPLEX	0.00934579	0.1710267293188289
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.00934579	0.1710267293188289
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00934579	0.1710267293188289
RHYNS SYNDROME; RHYNS	0.00934579	0.1710267293188289
3MC SYNDROME 1	0.00934579	0.1710267293188289
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00934579	0.1710267293188289
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.00934579	0.1710267293188289
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.00934579	0.1710267293188289
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.00934579	0.1710267293188289
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.00934579	0.1710267293188289
FONTAINE PROGEROID SYNDROME; FPS	0.00934579	0.1710267293188289
OTOSCLEROSIS	0.00934579	0.1710267293188289
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00934579	0.1710267293188289
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00934579	0.1710267293188289
TREACHER COLLINS SYNDROME 2; TCS2	0.00934579	0.1710267293188289
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.00934579	0.1710267293188289
#100800 ACHONDROPLASIA; ACH	0.00934579	0.1710267293188289
TREACHER COLLINS SYNDROME 3; TCS3	0.00934579	0.1710267293188289
OTOFACIOCERVICAL SYNDROME	0.00934579	0.1710267293188289
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00934579	0.1710267293188289
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.00934579	0.1710267293188289
DIAMOND-BLACKFAN ANEMIA 10	0.00934579	0.1710267293188289
CILIARY DYSKINESIA, PRIMARY, 33	0.00934579	0.1710267293188289
%608572 BURN-MCKEOWN SYNDROME	0.00934579	0.1710267293188289
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.00934579	0.1710267293188289
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.00934579	0.1710267293188289
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00934579	0.1710267293188289
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00934579	0.1710267293188289
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.00934579	0.1710267293188289
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.00934579	0.1710267293188289
FAMILIAL EXPANSILE OSTEOLYSIS	0.00934579	0.1710267293188289
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.00934579	0.1710267293188289
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.00930129	0.17021238516443554
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.00924491	0.16918063857062215
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00924491	0.16918063857062215
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00924491	0.16918063857062215
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00924491	0.16918063857062215
CLEIDOCRANIAL DYSPLASIA; CCD	0.00924491	0.16918063857062215
PRIMROSE SYNDROME; PRIMS	0.00924491	0.16918063857062215
MUCOPOLYSACCHARIDOSIS, TYPE II	0.00924491	0.16918063857062215
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00924432	0.16916984164812568
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.00924432	0.16916984164812568
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00899614	0.16462818024953368
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00899614	0.16462818024953368
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00899614	0.16462818024953368
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00899614	0.16462818024953368
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.00893917	0.16358563673322382
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00893917	0.16358563673322382
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00893917	0.16358563673322382
MASA SYNDROME	0.00893917	0.16358563673322382
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.00893917	0.16358563673322382
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00893917	0.16358563673322382
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.008908402000000001	0.16302258637496825
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.008908402000000001	0.16302258637496825
HYPEREKPLEXIA 4; HKPX4	0.008908402000000001	0.16302258637496825
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.008908402000000001	0.16302258637496825
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.008908402000000001	0.16302258637496825
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.008908402000000001	0.16302258637496825
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.008908402000000001	0.16302258637496825
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.008908402000000001	0.16302258637496825
SECKEL SYNDROME 8; SCKL8	0.008908402000000001	0.16302258637496825
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.008908402000000001	0.16302258637496825
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.008908402000000001	0.16302258637496825
CRI-DU-CHAT SYNDROME	0.00890405	0.1629429453466554
Myhre syndrome	0.00890405	0.1629429453466554
RENPENNING SYNDROME 1; RENS1	0.00890405	0.1629429453466554
Muenke syndrome	0.008669272	0.1586465387875506
RICHARDS-RUNDLE SYNDROME; RRNS	0.008669272	0.1586465387875506
DESANTO-SHINAWI SYNDROME	0.008669272	0.1586465387875506
DUANE-RADIAL RAY SYNDROME; DRRS	0.008655280000000001	0.158390487025567
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.008090262	0.1480507318474316
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.008090262	0.1480507318474316
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.008090262	0.1480507318474316
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008090262	0.1480507318474316
NIEMANN-PICK DISEASE, TYPE A	0.008090262	0.1480507318474316
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.008090262	0.1480507318474316
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.008090262	0.1480507318474316
NAVAJO NEUROHEPATOPATHY	0.008090262	0.1480507318474316
WARBURG MICRO SYNDROME 3; WARBM3	0.00806452	0.1475796566289508
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00806452	0.1475796566289508
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.00806452	0.1475796566289508
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00806452	0.1475796566289508
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00806452	0.1475796566289508
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.00806452	0.1475796566289508
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.00806452	0.1475796566289508
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00806452	0.1475796566289508
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00806452	0.1475796566289508
GERODERMA OSTEODYSPLASTICUM; GO	0.00806452	0.1475796566289508
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.00806452	0.1475796566289508
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00806452	0.1475796566289508
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00806452	0.1475796566289508
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00806452	0.1475796566289508
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.00806452	0.1475796566289508
#616470 ULLRICH CONGENITAL MUSCULAR DYSTROPHY 2; UCMD2	0.00806452	0.1475796566289508
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00806452	0.1475796566289508
%109500 BASILAR IMPRESSION, PRIMARY	0.00806452	0.1475796566289508
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00806452	0.1475796566289508
OROFACIODIGITAL SYNDROME XI; OFD11	0.00806452	0.1475796566289508
SCHOLTE SYNDROME; SHLTS	0.00806452	0.1475796566289508
NEMALINE MYOPATHY 4	0.00806452	0.1475796566289508
CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	0.00806452	0.1475796566289508
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00806452	0.1475796566289508
WARBURG MICRO SYNDROME 1	0.00806452	0.1475796566289508
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00806452	0.1475796566289508
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00806452	0.1475796566289508
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.00806452	0.1475796566289508
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00806452	0.1475796566289508
ACRORENAL-MANDIBULAR SYNDROME	0.00806452	0.1475796566289508
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00806452	0.1475796566289508
SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	0.00806452	0.1475796566289508
#117000 CENTRAL CORE DISEASE OF MUSCLE;;CCD;;CCOMINICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTICORE MYOPATHY, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;MULTIMINICORE DISEASE, MODERATE, WITH HAND INVOLVEMENT, INCLUDED;;NEUROMUSCULAR DISEASE, CONGENITAL, WITH UNIFORM TYPE 1 FIBER, INCLUDED;CNMDU1, INCLUDED	0.00806452	0.1475796566289508
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00806452	0.1475796566289508
#614815 JOUBERT SYNDROME 18; JBTS18	0.00806452	0.1475796566289508
MENTAL RETARDATION, X-LINKED 19	0.00806452	0.1475796566289508
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.00806452	0.1475796566289508
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00806452	0.1475796566289508
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0076006419999999995	0.13909075016486808
ROIFMAN-CHITAYAT SYNDROME	0.0076006419999999995	0.13909075016486808
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.0076006419999999995	0.13909075016486808
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.0076006419999999995	0.13909075016486808
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.0076006419999999995	0.13909075016486808
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0076006419999999995	0.13909075016486808
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.0076006419999999995	0.13909075016486808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0076006419999999995	0.13909075016486808
MENTAL RETARDATION, X-LINKED 91; MRX91	0.0076006419999999995	0.13909075016486808
#615665 JOUBERT SYNDROME 22; JBTS22	0.0076006419999999995	0.13909075016486808
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.0076006419999999995	0.13909075016486808
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0076006419999999995	0.13909075016486808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.0076006419999999995	0.13909075016486808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.0076006419999999995	0.13909075016486808
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0076006419999999995	0.13909075016486808
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.0076006419999999995	0.13909075016486808
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.0076006419999999995	0.13909075016486808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0076006419999999995	0.13909075016486808
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.0076006419999999995	0.13909075016486808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.0076006419999999995	0.13909075016486808
HOLOPROSENCEPHALY 5; HPE5	0.0076006419999999995	0.13909075016486808
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0076006419999999995	0.13909075016486808
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0076006419999999995	0.13909075016486808
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0076006419999999995	0.13909075016486808
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.0076006419999999995	0.13909075016486808
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.0076006419999999995	0.13909075016486808
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.0076006419999999995	0.13909075016486808
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.0076006419999999995	0.13909075016486808
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0076006419999999995	0.13909075016486808
#170100 PROLIDASE DEFICIENCY	0.0076006419999999995	0.13909075016486808
JOUBERT SYNDROME 35; JBTS35	0.0076006419999999995	0.13909075016486808
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.007295492	0.13350654524996622
PRADER-WILLI SYNDROME; PWS	0.007295492	0.13350654524996622
WIEACKER-WOLFF SYNDROME	0.007295492	0.13350654524996622
SHASHI-PENA SYNDROME; SHAPNS	0.007295492	0.13350654524996622
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.007295492	0.13350654524996622
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.007295492	0.13350654524996622
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.007295492	0.13350654524996622
SCHAAF-YANG SYNDROME; SHFYNG	0.007295492	0.13350654524996622
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.007295492	0.13350654524996622
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.007295492	0.13350654524996622
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.007295492	0.13350654524996622
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.007295492	0.13350654524996622
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.007295492	0.13350654524996622
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.007260372	0.1328638538633978
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.007260372	0.1328638538633978
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.007260372	0.1328638538633978
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.007260372	0.1328638538633978
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.007260372	0.1328638538633978
CHOPS SYNDROME; CHOPS	0.007260372	0.1328638538633978
ENTEROPATHY, FAMILIAL, WITH VILLOUS EDEMA AND IMMUNOGLOBULIN G2 DEFICIENCY	0.00724638	0.13260780210141418
ACID PHOSPHATASE DEFICIENCY	0.00724638	0.13260780210141418
LYSOSOMAL ACID LIPASE DEFICIENCY	0.00724638	0.13260780210141418
LESCH-NYHAN SYNDROME; LNS	0.00724638	0.13260780210141418
WOLMAN DISEASE WITH HYPOLIPOPROTEINEMIA AND ACANTHOCYTOSIS	0.00724638	0.13260780210141418
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE-2 DEFICIENCY	0.00724638	0.13260780210141418
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 3	0.00724638	0.13260780210141418
HYPERLIPOPROTEINEMIA, TYPE I	0.00724638	0.13260780210141418
5-@OXOPROLINASE DEFICIENCY; OPLAHD	0.00724638	0.13260780210141418
SUCCINYL-COA:3-OXOACID COA TRANSFERASE DEFICIENCY	0.00724638	0.13260780210141418
GITELMAN SYNDROME	0.00724638	0.13260780210141418
DIARRHEA 4, MALABSORPTIVE, CONGENITAL	0.00724638	0.13260780210141418
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 11	0.00724638	0.13260780210141418
MEDIUM CHAIN 3-KETOACYL-COA THIOLASE DEFICIENCY	0.00724638	0.13260780210141418
ALPHA-METHYLACETOACETIC ACIDURIA	0.00724638	0.13260780210141418
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00724638	0.13260780210141418
CAROLI DISEASE, ISOLATED	0.00724638	0.13260780210141418
DIARRHEA 7, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR7	0.00724638	0.13260780210141418
CONGENITAL SHORT BOWEL SYNDROME	0.00724638	0.13260780210141418
HYPERPARATHYROIDISM, NEONATAL SELF-LIMITED PRIMARY, WITH HYPERCALCIURIA	0.00724638	0.13260780210141418
HYPOADRENOCORTICISM, FAMILIAL	0.00724638	0.13260780210141418
#264350 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL RECESSIVE; PHA1B;;PHA I, AUTOSOMAL RECESSIVE	0.00724638	0.13260780210141418
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 1	0.00724638	0.13260780210141418
HYPER-IGD SYNDROME	0.00724638	0.13260780210141418
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.00724638	0.13260780210141418
HYPOPHOSPHATASIA, INFANTILE	0.00724638	0.13260780210141418
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00724638	0.13260780210141418
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.00724638	0.13260780210141418
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ib; CDG1B	0.00724638	0.13260780210141418
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00724638	0.13260780210141418
ANGIOEDEMA, HEREDITARY, TYPE I; HAE1	0.00724638	0.13260780210141418
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00724638	0.13260780210141418
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 10	0.00724638	0.13260780210141418
#203400 CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY;;CMO I DEFICIENCY;;ALDOSTERONE DEFICIENCY I;;HYPERRENINEMIC HYPOALDOSTERONISM, FAMILIAL, 1; FHHA1A;;ALDOSTERONE DEFICIENCY DUE TO DEFECT IN STEROID 18-HYDROXYLASE;;18-@HYDROXYLASE DEFICIENCY;;STEROID 18-@HYDROXYLASE DEFICIENCY	0.00724638	0.13260780210141418
COMPLEMENT HYPERACTIVATION, ANGIOPATHIC THROMBOSIS, AND PROTEIN-LOSING ENTEROPATHY; CHAPLE	0.00724638	0.13260780210141418
LYSINURIC PROTEIN INTOLERANCE; LPI	0.00724638	0.13260780210141418
VISCERAL MYOPATHY; VSCM	0.00724638	0.13260780210141418
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 5	0.00724638	0.13260780210141418
CHYLOMICRON RETENTION DISEASE	0.00724638	0.13260780210141418
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00724638	0.13260780210141418
#177735 PSEUDOHYPOALDOSTERONISM, TYPE I, AUTOSOMAL DOMINANT; PHA1A;;PHA I, AUTOSOMAL DOMINANT	0.00724638	0.13260780210141418
EPISODIC ATAXIA, TYPE 3	0.00724638	0.13260780210141418
MIGRAINE, FAMILIAL TYPICAL, SUSCEPTIBILITY TO, 2	0.00724638	0.13260780210141418
#231690 GLUTARIC ACIDURIA III;;GA III;;GLUTARYL-CoA OXIDASE DEFICIENCY	0.00724638	0.13260780210141418
LIVER FAILURE, INFANTILE, TRANSIENT	0.00724638	0.13260780210141418
PORPHYRIA VARIEGATA	0.00724638	0.13260780210141418
EPISODIC ATAXIA, TYPE 6	0.00724638	0.13260780210141418
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.00724638	0.13260780210141418
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 12; MGR12	0.00724638	0.13260780210141418
HYPERTHERMIA, CUTANEOUS, WITH HEADACHES AND NAUSEA	0.00724638	0.13260780210141418
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.00724638	0.13260780210141418
VALINEMIA	0.00724638	0.13260780210141418
MIGRAINE WITHOUT AURA, SUSCEPTIBILITY TO, 4	0.00724638	0.13260780210141418
VISCERAL NEUROPATHY, FAMILIAL, AUTOSOMAL RECESSIVE	0.00724638	0.13260780210141418
PORPHYRIA, ACUTE HEPATIC	0.00724638	0.13260780210141418
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00724638	0.13260780210141418
118301 CHARCOT-MARIE-TOOTH DISEASE WITH PTOSIS AND PARKINSONISM	0.00724638	0.13260780210141418
ANGIOEDEMA, HEREDITARY, TYPE III	0.00724638	0.13260780210141418
MIGRAINE WITH OR WITHOUT AURA, SUSCEPTIBILITY TO, 6	0.00724638	0.13260780210141418
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 34; COXPD34	0.00724638	0.13260780210141418
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00724638	0.13260780210141418
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00724638	0.13260780210141418
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.0070116020000000005	0.12831139554230936
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.007011602	0.12831139554230936
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.007011602	0.12831139554230936
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.007011602	0.12831139554230936
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.007011602	0.12831139554230936
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.007011602	0.12831139554230936
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.0069546320000000005	0.1272688520259995
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.006954632	0.1272688520259995
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.006954632	0.1272688520259995
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.006954632	0.1272688520259995
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.006954632	0.1272688520259995
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.006954632	0.1272688520259995
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.006954632	0.1272688520259995
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIj; CDG2J	0.00675676	0.12364782041885067
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00675676	0.12364782041885067
MENTAL RETARDATION, X-LINKED 14	0.00675676	0.12364782041885067
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00675676	0.12364782041885067
LUNG DISEASE, IMMUNODEFICIENCY, AND CHROMOSOME BREAKAGE SYNDROME; LICS	0.00675676	0.12364782041885067
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00675676	0.12364782041885067
SPINOCEREBELLAR ATAXIA 47; SCA47	0.00675676	0.12364782041885067
LICHTENSTEIN SYNDROME	0.00675676	0.12364782041885067
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00675676	0.12364782041885067
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00675676	0.12364782041885067
MENTAL RETARDATION, X-LINKED 100	0.00675676	0.12364782041885067
KENNERKNECHT SYNDROME	0.00675676	0.12364782041885067
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.00675676	0.12364782041885067
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00675676	0.12364782041885067
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00675676	0.12364782041885067
VERVERI-BRADY SYNDROME; VERBRAS	0.00675676	0.12364782041885067
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00675676	0.12364782041885067
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.00675676	0.12364782041885067
#611943 RIDDLE SYNDROME;;RADIOSENSITIVITY, IMMUNODEFICIENCY, DYSMORPHIC FEATURES, AND LEARNINGDIFFICULTIES	0.00675676	0.12364782041885067
IRIDOGONIODYSGENESIS, TYPE 2	0.00675676	0.12364782041885067
ZECHI-CEIDE SYNDROME	0.00675676	0.12364782041885067
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00675676	0.12364782041885067
RODRIGUES BLINDNESS	0.00675676	0.12364782041885067
HIRSCHSPRUNG DISEASE WITH HYPOPLASTIC NAILS AND DYSMORPHIC FACIALFEATURES	0.00675676	0.12364782041885067
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00675676	0.12364782041885067
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.00675676	0.12364782041885067
UROFACIAL SYNDROME	0.00675676	0.12364782041885067
601095 HARROD SYNDROME	0.00675676	0.12364782041885067
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00675676	0.12364782041885067
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.00675676	0.12364782041885067
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00675676	0.12364782041885067
#612292 BIRK-BAREL MENTAL RETARDATION DYSMORPHISM SYNDROME;;BIRK-BAREL SYNDROME;;MENTAL RETARDATION WITH HYPOTONIA AND FACIAL DYSMORPHISM	0.00675676	0.12364782041885067
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.00675676	0.12364782041885067
HAIRY ELBOWS	0.00675676	0.12364782041885067
EPILEPSY-TELANGIECTASIA	0.00675676	0.12364782041885067
FACIAL DYSMORPHISM, LENS DISLOCATION, ANTERIOR SEGMENT ABNORMALITIES, AND SPONTANEOUS FILTERING BLEBS; FDLAB	0.00675676	0.12364782041885067
DIAMOND-BLACKFAN ANEMIA 4	0.00675676	0.12364782041885067
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00675676	0.12364782041885067
#615139 FACIAL DYSMORPHISM, IMMUNODEFICIENCY, LIVEDO, AND SHORT STATURE; FILS	0.00675676	0.12364782041885067
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.00675676	0.12364782041885067
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00675676	0.12364782041885067
233430 GONADAL DYSGENESIS, XY TYPE, WITH ASSOCIATED ANOMALIES	0.00675676	0.12364782041885067
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.00675676	0.12364782041885067
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.00675676	0.12364782041885067
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00675676	0.12364782041885067
SPONDYLOCOSTAL DYSOSTOSIS 3, AUTOSOMAL RECESSIVE; SCDO3	0.00645161	0.11806361550394881
#113500 BRACHYOLMIA TYPE 3;;BRACHYOLMIA, AUTOSOMAL DOMINANT;;BRACHYRACHIA	0.00645161	0.11806361550394881
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00645161	0.11806361550394881
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00645161	0.11806361550394881
EHLERS-DANLOS SYNDROME, TYPE VI	0.00645161	0.11806361550394881
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00645161	0.11806361550394881
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00645161	0.11806361550394881
Ullrich congenital muscular dystrophy 1	0.00645161	0.11806361550394881
PSEUDOACHONDROPLASIA	0.00645161	0.11806361550394881
#278250 WRINKLY SKIN SYNDROME; WSS	0.00645161	0.11806361550394881
#606612 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH OR WITHOUTMENTAL RETARDATION), TYPE B, 5; MDDGB5;;MUSCULAR DYSTROPHY, CONGENITAL, 1C; MDC1C;;MUSCULAR DYSTROPHY, CONGENITAL, FKRP-RELATED	0.00645161	0.11806361550394881
#255200 MYOPATHY, CENTRONUCLEAR, 2; CNM2;;MYOPATHY, CENTRONUCLEAR, AUTOSOMAL RECESSIVE;;MYOTUBULAR MYOPATHY, AUTOSOMAL RECESSIVE	0.00645161	0.11806361550394881
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.00645161	0.11806361550394881
#300718 MYOPATHY, REDUCING BODY, X-LINKED, CHILDHOOD-ONSET	0.00645161	0.11806361550394881
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00645161	0.11806361550394881
ATKIN-FLAITZ SYNDROME	0.00645161	0.11806361550394881
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.00645161	0.11806361550394881
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.00645161	0.11806361550394881
HURLER-SCHEIE SYNDROME	0.00645161	0.11806361550394881
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.00645161	0.11806361550394881
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00645161	0.11806361550394881
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.00645161	0.11806361550394881
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.00645161	0.11806361550394881
OROFACIODIGITAL SYNDROME III	0.00645161	0.11806361550394881
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00645161	0.11806361550394881
#600175 SPINAL MUSCULAR ATROPHY, DISTAL, CONGENITAL NONPROGRESSIVE;;SPINAL MUSCULAR ATROPHY, CONGENITAL BENIGN, WITH CONTRACTURES	0.00645161	0.11806361550394881
DESBUQUOIS DYSPLASIA 1	0.00645161	0.11806361550394881
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00645161	0.11806361550394881
CLARK-BARAITSER SYNDROME	0.00645161	0.11806361550394881
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.00645161	0.11806361550394881
SCHEUERMANN DISEASE	0.00645161	0.11806361550394881
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00645161	0.11806361550394881
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00645161	0.11806361550394881
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.00645161	0.11806361550394881
RETT SYNDROME, CONGENITAL VARIANT	0.00645161	0.11806361550394881
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.00645161	0.11806361550394881
SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA	0.00645161	0.11806361550394881
RUVALCABA SYNDROME	0.00645161	0.11806361550394881
#230650 GM1-GANGLIOSIDOSIS, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, ADULT TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, CHRONIC TYPE;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE III;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 3	0.00645161	0.11806361550394881
BETHLEM MYOPATHY 2; BTHLM2	0.00645161	0.11806361550394881
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00645161	0.11806361550394881
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.00645161	0.11806361550394881
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.00645161	0.11806361550394881
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.00645161	0.11806361550394881
SPONDYLOARTHROPATHY, SUSCEPTIBILITY TO, 1	0.00645161	0.11806361550394881
METATROPIC DYSPLASIA	0.00645161	0.11806361550394881
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.00645161	0.11806361550394881
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.00645161	0.11806361550394881
MENTAL RETARDATION, X-LINKED 82	0.00645161	0.11806361550394881
LOWE OCULOCEREBRORENAL SYNDROME	0.00645161	0.11806361550394881
#168400 PARASTREMMATIC DWARFISM	0.00645161	0.11806361550394881
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00641649	0.1174209241173804
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00641649	0.1174209241173804
SPASTIC PARAPARESIS AND DEAFNESS	0.00641649	0.1174209241173804
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00641649	0.1174209241173804
NATHALIE SYNDROME	0.00641649	0.1174209241173804
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00641649	0.1174209241173804
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00641649	0.1174209241173804
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00641649	0.1174209241173804
LISSENCEPHALY 5; LIS5	0.00641649	0.1174209241173804
STICKLER SYNDROME, TYPE II	0.00616772	0.11286846579629196
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00616772	0.11286846579629196
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00616772	0.11286846579629196
SHORT SYNDROME	0.00616772	0.11286846579629196
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.00616772	0.11286846579629196
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00616772	0.11286846579629196
REFSUM DISEASE	0.00616772	0.11286846579629196
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00616772	0.11286846579629196
NAIL-PATELLA SYNDROME	0.00616772	0.11286846579629196
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00616772	0.11286846579629196
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00616772	0.11286846579629196
NEURAMINIDASE DEFICIENCY	0.00616772	0.11286846579629196
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00616772	0.11286846579629196
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.00616772	0.11286846579629196
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00616772	0.11286846579629196
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.006124742000000001	0.11208197404196574
COFFIN-SIRIS SYNDROME 7; CSS7	0.006124742000000001	0.11208197404196574
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.006124742000000001	0.11208197404196574
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.006124742000000001	0.11208197404196574
OPTIC ATROPHY 11; OPA11	0.006124742000000001	0.11208197404196574
KABUKI SYNDROME 1	0.006124742000000001	0.11208197404196574
RECOMBINANT CHROMOSOME 8 SYNDROME	0.006124742000000001	0.11208197404196574
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.006124742000000001	0.11208197404196574
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.006124742	0.11208197404196571
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.006124742	0.11208197404196571
#129500 CLOUSTON SYNDROME;;ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE; ECTD2;;ECTODERMAL DYSPLASIA, HIDROTIC, AUTOSOMAL DOMINANT;;CLOUSTON HIDROTIC ECTODERMAL DYSPLASIA;;ECTODERMAL DYSPLASIA, HIDROTIC, 2, FORMERLY; HED2, FORMERLY	0.00611075	0.11182592227998209
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00611075	0.11182592227998209
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00611075	0.11182592227998209
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00611075	0.11182592227998209
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00611075	0.11182592227998209
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00611075	0.11182592227998209
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.00611075	0.11182592227998209
LEBER CONGENITAL AMAUROSIS 16	0.00611075	0.11182592227998209
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.00611075	0.11182592227998209
CRANIOSYNOSTOSIS 6; CRS6	0.005875972	0.1075295157208773
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.005875972	0.1075295157208773
HYPERTRYPTOPHANEMIA; HYPTRP	0.005875972	0.1075295157208773
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.005875972	0.1075295157208773
LEIGH SYNDROME; LS	0.005875972	0.1075295157208773
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.005875972	0.1075295157208773
Pontine tegmental cap dysplasia	0.005875972	0.1075295157208773
CHROMOSOME 10Q26 DELETION SYNDROME	0.005875972	0.1075295157208773
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.005875972	0.1075295157208773
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00533783	0.0976815878122582
AYME-GRIPP SYNDROME; AYGRP	0.00533783	0.0976815878122582
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.00533783	0.0976815878122582
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00533783	0.0976815878122582
COWCHOCK SYNDROME; COWCK	0.00533783	0.0976815878122582
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00533783	0.0976815878122582
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00528086	0.09663904429594833
IVIC SYNDROME	0.00528086	0.09663904429594833
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.00528086	0.09663904429594833
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.00528086	0.09663904429594833
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.00528086	0.09663904429594833
ACROCALLOSAL SYNDROME; ACLS	0.00528086	0.09663904429594833
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00503209	0.09208658597485989
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00503209	0.09208658597485989
JOHANSON-BLIZZARD SYNDROME; JBS	0.00503209	0.09208658597485989
15q26 overgrowth syndrome	0.00503209	0.09208658597485989
CHANARIN-DORFMAN SYNDROME	0.00503209	0.09208658597485989
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00503209	0.09208658597485989
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00503209	0.09208658597485989
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.004467072	0.08174683079672448
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.004467072	0.08174683079672448
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.004467072	0.08174683079672448
PEROXISOME BIOGENESIS DISORDER 10B	0.004467072	0.08174683079672448
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004467072	0.08174683079672448
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.004467072	0.08174683079672448
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.004467072	0.08174683079672448
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.004467072	0.08174683079672448
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.004467072	0.08174683079672448
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.004467072	0.08174683079672448
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.004467072	0.08174683079672448
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.004467072	0.08174683079672448
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.004467072	0.08174683079672448
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.004467072	0.08174683079672448
LISSENCEPHALY 8; LIS8	0.004467072	0.08174683079672448
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004467072	0.08174683079672448
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.004467072	0.08174683079672448
PELLAGRA-LIKE SYNDROME	0.004467072	0.08174683079672448
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.004467072	0.08174683079672448
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.004467072	0.08174683079672448
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.004467072	0.08174683079672448
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.004467072	0.08174683079672448
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.004467072	0.08174683079672448
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.003637182	0.06655995281269073
COFFIN-SIRIS SYNDROME 3; CSS3	0.003637182	0.06655995281269073
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.003637182	0.06655995281269073
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.003637182	0.06655995281269073
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.003637182	0.06655995281269073
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.003637182	0.06655995281269073
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.003637182	0.06655995281269073
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.003637182	0.06655995281269073
GENITOPATELLAR SYNDROME; GTPTS	0.003637182	0.06655995281269073
CORNELIA DE LANGE SYNDROME 3	0.003637182	0.06655995281269073
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.003637182	0.06655995281269073
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.003637182	0.06655995281269073
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.003637182	0.06655995281269073
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.003637182	0.06655995281269073
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.003637182	0.06655995281269073
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.003637182	0.06655995281269073
SMITH-MAGENIS SYNDROME; SMS	0.003637182	0.06655995281269073
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.003637182	0.06655995281269073
POTOCKI-LUPSKI SYNDROME	0.003637182	0.06655995281269073
HYDROXYKYNURENINURIA	0.003637182	0.06655995281269073
CHROMOSOME 1p35 DELETION SYNDROME	0.003637182	0.06655995281269073
SWEENEY-COX SYNDROME; SWCOS	0.003637182	0.06655995281269073
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.003637182	0.06655995281269073
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.003637182	0.06655995281269073
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.003637182	0.06655995281269073
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.003637182	0.06655995281269073
PELIZAEUS-MERZBACHER DISEASE	0.003637182	0.06655995281269073
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.003637182	0.06655995281269073
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.003637182	0.06655995281269073
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.003637182	0.06655995281269073
WARSAW BREAKAGE SYNDROME; WABS	0.003637182	0.06655995281269073
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003637182	0.06655995281269073
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.003637182	0.06655995281269073
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.003637182	0.06655995281269073
COFFIN-SIRIS SYNDROME 4; CSS4	0.003637182	0.06655995281269073
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.003637182	0.06655995281269073
LYMPHEDEMA, HEREDITARY, III	0.003637182	0.06655995281269073
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.003637182	0.06655995281269073
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00362319	0.06630390105070709
#616395 TRICHOTHIODYSTROPHY 3, PHOTOSENSITIVE; TTD3 ;;TRICHOTHIODYSTROPHY, COMPLEMENTATION GROUP A; TTDA	0.00362319	0.06630390105070709
116100 CATARACT, MEMBRANOUS	0.00362319	0.06630390105070709
#262300 ACHROMATOPSIA 3; ACHM3;;PINGELAPESE BLINDNESS;;TOTAL COLORBLINDNESS WITH MYOPIA;;ACHROMATOPSIA WITH MYOPIA;;ACHM1, FORMERLY;;ROD MONOCHROMATISM 1, FORMERLY;;ROD MONOCHROMACY 1, FORMERLY; RMCH1, FORMERLY	0.00362319	0.06630390105070709
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00362319	0.06630390105070709
#612462 PSEUDOHYPOPARATHYROIDISM, TYPE IC; PHP1C;;PHP IC	0.00362319	0.06630390105070709
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.00362319	0.06630390105070709
ANTERIOR SEGMENT DYSGENESIS 8	0.00362319	0.06630390105070709
RETINITIS PIGMENTOSA 4; RP4	0.00362319	0.06630390105070709
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00362319	0.06630390105070709
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00362319	0.06630390105070709
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00362319	0.06630390105070709
ENHANCED S-CONE SYNDROME	0.00362319	0.06630390105070709
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00362319	0.06630390105070709
HYPERTROPHIC NEUROPATHY AND CATARACT	0.00362319	0.06630390105070709
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00362319	0.06630390105070709
#256520 NEU-LAXOVA SYNDROME; NLS	0.00362319	0.06630390105070709
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.00362319	0.06630390105070709
#614292 MYOPIA, HIGH, WITH CATARACT AND VITREORETINAL DEGENERATION; MCVD	0.00362319	0.06630390105070709
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00362319	0.06630390105070709
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.00362319	0.06630390105070709
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.00362319	0.06630390105070709
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00362319	0.06630390105070709
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.00362319	0.06630390105070709
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00362319	0.06630390105070709
#613826 LEBER CONGENITAL AMAUROSIS 6; LCA6	0.00362319	0.06630390105070709
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00362319	0.06630390105070709
#613887 CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 4; CATC4	0.00362319	0.06630390105070709
HYPOGONADISM-CATARACT SYNDROME	0.00362319	0.06630390105070709
PHENYLKETONURIA	0.00362319	0.06630390105070709
CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT	0.00362319	0.06630390105070709
#612463 PSEUDOPSEUDOHYPOPARATHYROIDISM; PPHP;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITHOUT MULTIPLE HORMONE RESISTANCE	0.00362319	0.06630390105070709
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.00362319	0.06630390105070709
#610092 MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 3; MCOPCB3;;MICROPHTHALMIA, COLOBOMATOUS, ISOLATED 3MICROPHTHALMIA, CATARACTS, AND IRIS ABNORMALITIES, INCLUDED	0.00362319	0.06630390105070709
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00362319	0.06630390105070709
ANIRIDIA	0.00362319	0.06630390105070709
#180104 RETINITIS PIGMENTOSA 9; RP9	0.00362319	0.06630390105070709
ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT	0.00362319	0.06630390105070709
MEGALOCORNEA	0.00362319	0.06630390105070709
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.00362319	0.06630390105070709
MICROPHTHALMIA, ISOLATED 5	0.00362319	0.06630390105070709
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.00362319	0.06630390105070709
#612018 CATARACT, JUVENILE, WITH MICROCORNEA AND GLUCOSURIA;;CJMG	0.00362319	0.06630390105070709
#608810 MYOPATHY, MYOFIBRILLAR, 2, MFM2;;MYOPATHY, MYOFIBRILLAR, ALPHA-B CRYSTALLIN-RELATED;;MYOPATHY, DESMIN-RELATED, ASSOCIATED WITH MUTATION IN THE CRYAB GENE;;ALPHA-B CRYSTALLINOPATHY	0.00362319	0.06630390105070709
STROMME SYNDROME; STROMS	0.00362319	0.06630390105070709
CATARACT AND CONGENITAL ICHTHYOSIS	0.00362319	0.06630390105070709
#613150 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 2; MDDGA2;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, POMT2-RELATED	0.00362319	0.06630390105070709
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00362319	0.06630390105070709
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.00362319	0.06630390105070709
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00362319	0.06630390105070709
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00362319	0.06630390105070709
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.00362319	0.06630390105070709
ANIRIDIA 2	0.00362319	0.06630390105070709
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00362319	0.06630390105070709
#613829 LEBER CONGENITAL AMAUROSIS 7; LCA7	0.00362319	0.06630390105070709
EXFOLIATION SYNDROME; XFS	0.00362319	0.06630390105070709
RETINITIS PIGMENTOSA 84; RP84	0.00362319	0.06630390105070709
#615418 MITOCHONDRIAL DNA DEPLETION SYNDROME 12 (CARDIOMYOPATHIC TYPE); MTDPS12	0.00362319	0.06630390105070709
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00362319	0.06630390105070709
ANIRIDIA AND ABSENT PATELLA	0.00362319	0.06630390105070709
#612109 OCULOAURICULAR SYNDROME; OCACS;;MICROPHTHALMIA, MICROCORNEA, ANTERIOR SEGMENT DYSGENESIS, CATARACT,OCULAR COLOBOMA, RETINAL PIGMENT EPITHELIUM ABNORMALITIES, ROD-CONEDYSTROPHY, AND ANOMALIES OF THE EXTERNAL EAR;;SCHORDERET-MUNIER-FRANCESCHETTI SYNDROME	0.00362319	0.06630390105070709
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.00362319	0.06630390105070709
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.00362319	0.06630390105070709
MYOTONIC DYSTROPHY 1	0.00362319	0.06630390105070709
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00362319	0.06630390105070709
%609376 CATARACT 35; CTRCT35;;CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	0.00362319	0.06630390105070709
TRICHOMEGALY; TCMGLY	0.00362319	0.06630390105070709
#610019 CATARACT, AUTOSOMAL RECESSIVE CONGENITAL 2; CATC2	0.00362319	0.06630390105070709
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00362319	0.06630390105070709
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00362319	0.06630390105070709
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.00362319	0.06630390105070709
VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	0.00362319	0.06630390105070709
#103580 PSEUDOHYPOPARATHYROIDISM, TYPE IA; PHP1A;;PHP IA;;ALBRIGHT HEREDITARY OSTEODYSTROPHY WITH MULTIPLE HORMONE RESISTANCE	0.00362319	0.06630390105070709
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00362319	0.06630390105070709
CONE-ROD DYSTROPHY 16	0.00362319	0.06630390105070709
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00362319	0.06630390105070709
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00362319	0.06630390105070709
BARDET-BIEDL SYNDROME 18; BBS18	0.00362319	0.06630390105070709
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00362319	0.06630390105070709
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00362319	0.06630390105070709
#614878 AUTOINFLAMMATION, ANTIBODY DEFICIENCY, AND IMMUNE DYSREGULATION, PLCG2-ASSOCIATED;APLAID	0.00362319	0.06630390105070709
DERMATITIS, ATOPIC	0.00362319	0.06630390105070709
#613154 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYEANOMALIES), TYPE A, 6; MDDGA6;;WALKER-WARBURG SYNDROME OR MUSCLE-EYE-BRAIN DISEASE, LARGE-RELATED	0.00362319	0.06630390105070709
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00362319	0.06630390105070709
#612285 JOUBERT SYNDROME 9; JBTS9JOUBERT SYNDROME 9/15, DIGENIC, INCLUDED	0.00362319	0.06630390105070709
#312600 RETINITIS PIGMENTOSA 2; RP2	0.00362319	0.06630390105070709
#221900 PERSISTENT HYPERPLASTIC PRIMARY VITREOUS, AUTOSOMAL RECESSIVE; PHPVAR;;RETINAL NONATTACHMENT, NONSYNDROMIC CONGENITAL; RNANC; NCRNA;;RETINAL NONATTACHMENT AND FALCIFORM DETACHMENT;;PERSISTENT FETAL VASCULATURE	0.00362319	0.06630390105070709
IRIS PIGMENT LAYER, CLEAVAGE OF	0.00362319	0.06630390105070709
GALACTOKINASE DEFICIENCY	0.00362319	0.06630390105070709
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00362319	0.06630390105070709
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.00362319	0.06630390105070709
#143200 WAGNER VITREORETINOPATHY; WGVRP;;EROSIVE VITREORETINOPATHY; ERVR;;WAGNER VITREORETINAL DEGENERATION;;HYALOIDEORETINAL DEGENERATION OF WAGNER;;WAGNER SYNDROME 1; WGN1	0.00362319	0.06630390105070709
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	0.00362319	0.06630390105070709
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.00362319	0.06630390105070709
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00362319	0.06630390105070709
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00362319	0.06630390105070709
#611131 RETINITIS PIGMENTOSA 37; RP37	0.00362319	0.06630390105070709
ANIRIDIA 3	0.00362319	0.06630390105070709
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00362319	0.06630390105070709
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.00362319	0.06630390105070709
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.00362319	0.06630390105070709
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.00362319	0.06630390105070709
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00362319	0.06630390105070709
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.00362319	0.06630390105070709
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00362319	0.06630390105070709
MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM	0.00362319	0.06630390105070709
CATARACT, CRYSTALLINE CORALLIFORM	0.00362319	0.06630390105070709
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.00362319	0.06630390105070709
#269400 CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES; COPOA;;SCLEROCORNEA WITH OTHER OCULAR ANOMALIES	0.00362319	0.06630390105070709
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0033884120000000004	0.06200749449160229
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0033884120000000004	0.06200749449160229
PEROXISOME BIOGENESIS DISORDER 3B	0.0033884120000000004	0.06200749449160229
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.0033884120000000004	0.06200749449160229
PEROXISOME BIOGENESIS DISORDER 6B	0.0033884120000000004	0.06200749449160229
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0033884120000000004	0.06200749449160229
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0033884120000000004	0.06200749449160229
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.0033884120000000004	0.06200749449160229
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.0033884120000000004	0.06200749449160229
PEROXISOME BIOGENESIS DISORDER 5B	0.0033884120000000004	0.06200749449160229
NOONAN SYNDROME 11; NS11	0.0033884120000000004	0.06200749449160229
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0033884120000000004	0.06200749449160229
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0033884120000000004	0.06200749449160229
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.0033884120000000004	0.06200749449160229
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0033884120000000004	0.06200749449160229
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0033884120000000004	0.06200749449160229
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.0033884120000000004	0.06200749449160229
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0033884120000000004	0.06200749449160229
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0033884120000000004	0.06200749449160229
INFANTILE LIVER FAILURE SYNDROME 1	0.0033884120000000004	0.06200749449160229
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0033884120000000004	0.06200749449160229
CHROMOSOME 2q37 DELETION SYNDROME	0.0033884120000000004	0.06200749449160229
VICI SYNDROME; VICIS	0.0033884120000000004	0.06200749449160229
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0033884120000000004	0.06200749449160229
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0033884120000000004	0.06200749449160229
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.0033884120000000004	0.06200749449160229
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0033884120000000004	0.06200749449160229
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0033884120000000004	0.06200749449160229
TOWNES-BROCKS SYNDROME 1; TBS1	0.0033884120000000004	0.06200749449160229
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0033884120000000004	0.06200749449160229
STEEL SYNDROME; STLS	0.0033884120000000004	0.06200749449160229
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0033884120000000004	0.06200749449160229
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0033884120000000004	0.06200749449160229
WAARDENBURG-SHAH SYNDROME	0.0033884120000000004	0.06200749449160229
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0033884120000000004	0.06200749449160229
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0033884120000000004	0.06200749449160229
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0033884120000000004	0.06200749449160229
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0033884120000000004	0.06200749449160229
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0033884120000000004	0.06200749449160229
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.0033884120000000004	0.06200749449160229
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.0033884120000000004	0.06200749449160229
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0033884120000000004	0.06200749449160229
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.0033884120000000004	0.06200749449160229
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0033884120000000004	0.06200749449160229
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0033884120000000004	0.06200749449160229
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0033314420000000004	0.06096495097529242
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.0033314420000000004	0.06096495097529242
HADZISELIMOVIC SYNDROME	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, X-LINKED 104; MRX104	0.0033314420000000004	0.06096495097529242
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.0033314420000000004	0.06096495097529242
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.0033314420000000004	0.06096495097529242
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.0033314420000000004	0.06096495097529242
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.0033314420000000004	0.06096495097529242
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.0033314420000000004	0.06096495097529242
SENIOR-LOKEN SYNDROME 9	0.0033314420000000004	0.06096495097529242
ADENYLOSUCCINASE DEFICIENCY	0.0033314420000000004	0.06096495097529242
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.0033314420000000004	0.06096495097529242
Mental retardation, autosomal dominant 21	0.0033314420000000004	0.06096495097529242
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.0033314420000000004	0.06096495097529242
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.0033314420000000004	0.06096495097529242
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0033314420000000004	0.06096495097529242
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.0033314420000000004	0.06096495097529242
OCULOECTODERMAL SYNDROME; OES	0.0033314420000000004	0.06096495097529242
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.0033314420000000004	0.06096495097529242
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.0033314420000000004	0.06096495097529242
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.0033314420000000004	0.06096495097529242
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.0033314420000000004	0.06096495097529242
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.0033314420000000004	0.06096495097529242
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.0033314420000000004	0.06096495097529242
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.0033314420000000004	0.06096495097529242
C SYNDROME	0.0033314420000000004	0.06096495097529242
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0033314420000000004	0.06096495097529242
ADAMS-OLIVER SYNDROME 2; AOS2	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0033314420000000004	0.06096495097529242
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0033314420000000004	0.06096495097529242
BAKER-GORDON SYNDROME; BAGOS	0.0033314420000000004	0.06096495097529242
NEPHRONOPHTHISIS 11; NPHP11	0.0033314420000000004	0.06096495097529242
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0033314420000000004	0.06096495097529242
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.0033314420000000004	0.06096495097529242
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0033314420000000004	0.06096495097529242
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.0033314420000000004	0.06096495097529242
MEHMO SYNDROME; MEHMO	0.0033314420000000004	0.06096495097529242
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.0033314420000000004	0.06096495097529242
SCHINDLER DISEASE, TYPE I	0.0033314420000000004	0.06096495097529242
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.0033314420000000004	0.06096495097529242
Aarskog-Scott syndrome	0.0033314420000000004	0.06096495097529242
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.0033314420000000004	0.06096495097529242
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.0033314420000000004	0.06096495097529242
MUCOLIPIDOSIS IV; ML4	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.0033314420000000004	0.06096495097529242
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.0033314420000000004	0.06096495097529242
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0033314420000000004	0.06096495097529242
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.0033314420000000004	0.06096495097529242
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.0033314420000000004	0.06096495097529242
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0033314420000000004	0.06096495097529242
CHAR SYNDROME	0.0033314420000000004	0.06096495097529242
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.0033314420000000004	0.06096495097529242
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0033314420000000004	0.06096495097529242
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.0033314420000000004	0.06096495097529242
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.0033314420000000004	0.06096495097529242
GABRIELE-DE VRIES SYNDROME; GADEVS	0.0033314420000000004	0.06096495097529242
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0033314420000000004	0.06096495097529242
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.0033314420000000004	0.06096495097529242
ANGELMAN SYNDROME	0.0033314420000000004	0.06096495097529242
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.0033314420000000004	0.06096495097529242
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0033314420000000004	0.06096495097529242
Helsmoortel-van der Aa syndrome	0.0033314420000000004	0.06096495097529242
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.0033314420000000004	0.06096495097529242
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.0033314420000000004	0.06096495097529242
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.0033314420000000004	0.06096495097529242
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.0033314420000000004	0.06096495097529242
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.0033314420000000004	0.06096495097529242
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.0033314420000000004	0.06096495097529242
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.0033314420000000004	0.06096495097529242
CHROMOSOME 17P13.1 DELETION SYNDROME	0.0033314420000000004	0.06096495097529242
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, X-LINKED 90	0.0033314420000000004	0.06096495097529242
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.0033314420000000004	0.06096495097529242
RAYNAUD-CLAES SYNDROME; MRXSRC	0.0033314420000000004	0.06096495097529242
JOUBERT SYNDROME 31; JBTS31	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0033314420000000004	0.06096495097529242
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.0033314420000000004	0.06096495097529242
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0033314420000000004	0.06096495097529242
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.0033314420000000004	0.06096495097529242
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.0033314420000000004	0.06096495097529242
GAUCHER DISEASE, TYPE II	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, X-LINKED 101; MRX101	0.0033314420000000004	0.06096495097529242
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.0033314420000000004	0.06096495097529242
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0033314420000000004	0.06096495097529242
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.0033314420000000004	0.06096495097529242
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0033314420000000004	0.06096495097529242
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.0033314420000000004	0.06096495097529242
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.0033314420000000004	0.06096495097529242
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0033314420000000004	0.06096495097529242
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0033314420000000004	0.06096495097529242
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.0033314420000000004	0.06096495097529242
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.0027933000000000003	0.051117023066673324
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0027933000000000003	0.051117023066673324
WILDERVANCK SYNDROME	0.0027933000000000003	0.051117023066673324
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0027933000000000003	0.051117023066673324
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.0027933000000000003	0.051117023066673324
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.0027933000000000003	0.051117023066673324
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.0027933000000000003	0.051117023066673324
BARBER-SAY SYNDROME; BBRSAY	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.0027933000000000003	0.051117023066673324
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.0027933000000000003	0.051117023066673324
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.0027933000000000003	0.051117023066673324
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.0027933000000000003	0.051117023066673324
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL DOMINANT 24	0.0027933000000000003	0.051117023066673324
#614944 DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B	0.0027933000000000003	0.051117023066673324
DEAFNESS, X-LINKED 7; DFNX7	0.0027933000000000003	0.051117023066673324
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.0027933000000000003	0.051117023066673324
RETINAL VENOUS BEADING	0.0027933000000000003	0.051117023066673324
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.0027933000000000003	0.051117023066673324
SCLEROSTEOSIS 2; SOST2	0.0027933000000000003	0.051117023066673324
#602459 DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15	0.0027933000000000003	0.051117023066673324
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.0027933000000000003	0.051117023066673324
FEINGOLD SYNDROME 1; FGLDS1	0.0027933000000000003	0.051117023066673324
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.0027933000000000003	0.051117023066673324
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.0027933000000000003	0.051117023066673324
BRANCHIOOTIC SYNDROME 2	0.0027933000000000003	0.051117023066673324
DYSOSTEOSCLEROSIS	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.0027933000000000003	0.051117023066673324
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.0027933000000000003	0.051117023066673324
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.0027933000000000003	0.051117023066673324
#613558 DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51;;CHROMOSOME 9Q21.11 DUPLICATION SYNDROME	0.0027933000000000003	0.051117023066673324
3MC SYNDROME 3	0.0027933000000000003	0.051117023066673324
#610896 BRANCHIOOTORENAL SYNDROME 2; BOR2	0.0027933000000000003	0.051117023066673324
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.0027933000000000003	0.051117023066673324
BRITTLE CORNEA SYNDROME 2; BCS2	0.0027933000000000003	0.051117023066673324
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.0027933000000000003	0.051117023066673324
OTOSCLEROSIS 8; OTSC8	0.0027933000000000003	0.051117023066673324
OPTICOCOCHLEODENTATE DEGENERATION	0.0027933000000000003	0.051117023066673324
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0027933000000000003	0.051117023066673324
#158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;;FSHD2, DIGENIC;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B	0.0027933000000000003	0.051117023066673324
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.0027933000000000003	0.051117023066673324
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.0027933000000000003	0.051117023066673324
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.0027933000000000003	0.051117023066673324
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.0027933000000000003	0.051117023066673324
CAMURATI-ENGELMANN DISEASE	0.0027933000000000003	0.051117023066673324
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.0027933000000000003	0.051117023066673324
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.0027933000000000003	0.051117023066673324
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.0027933000000000003	0.051117023066673324
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.051117023066673324
OTOSCLEROSIS 3; OTSC3	0.0027933000000000003	0.051117023066673324
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.0027933000000000003	0.051117023066673324
USHER SYNDROME, TYPE ID	0.0027933000000000003	0.051117023066673324
DEMENTIA, FAMILIAL DANISH	0.0027933000000000003	0.051117023066673324
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0027933000000000003	0.051117023066673324
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.0027933000000000003	0.051117023066673324
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0027933000000000003	0.051117023066673324
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.051117023066673324
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.051117023066673324
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.0027933000000000003	0.051117023066673324
XYLOSIDASE DEFICIENCY	0.0027933000000000003	0.051117023066673324
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.0027933000000000003	0.051117023066673324
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.0027933000000000003	0.051117023066673324
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0027933000000000003	0.051117023066673324
ABCD SYNDROME	0.0027933000000000003	0.051117023066673324
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0027933000000000003	0.051117023066673324
FETAL IODINE DEFICIENCY DISORDER	0.0027933000000000003	0.051117023066673324
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.0027933000000000003	0.051117023066673324
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.0027933000000000003	0.051117023066673324
TUNE DEAFNESS	0.0027933000000000003	0.051117023066673324
#606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	0.0027933000000000003	0.051117023066673324
MENIERE DISEASE	0.0027933000000000003	0.051117023066673324
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.0027933000000000003	0.051117023066673324
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.0027933000000000003	0.051117023066673324
GLYCOGEN STORAGE DISEASE II	0.0027933000000000003	0.051117023066673324
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0027933000000000003	0.051117023066673324
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.0027933000000000003	0.051117023066673324
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0027933000000000003	0.051117023066673324
AUROCEPHALOSYNDACTYLY	0.0027933000000000003	0.051117023066673324
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.0027933000000000003	0.051117023066673324
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0027933000000000003	0.051117023066673324
SIFRIM-HITZ-WEISS SYNDROME	0.0027933000000000003	0.051117023066673324
#615429 DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88	0.0027933000000000003	0.051117023066673324
#614934 DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70	0.0027933000000000003	0.051117023066673324
CANAVAN DISEASE	0.0027933000000000003	0.051117023066673324
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.0027933000000000003	0.051117023066673324
COXOAURICULAR SYNDROME	0.0027933000000000003	0.051117023066673324
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.0027933000000000003	0.051117023066673324
#613718 DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74	0.0027933000000000003	0.051117023066673324
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027933000000000003	0.051117023066673324
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.0027933000000000003	0.051117023066673324
CONE-ROD DYSTROPHY 1; CORD1	0.0027933000000000003	0.051117023066673324
PAGET DISEASE OF BONE 4; PDB4	0.0027933000000000003	0.051117023066673324
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.0027933000000000003	0.051117023066673324
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.0027933000000000003	0.051117023066673324
ANUS, IMPERFORATE	0.0027933000000000003	0.051117023066673324
SCLEROSTEOSIS 1; SOST1	0.0027933000000000003	0.051117023066673324
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0027933000000000003	0.051117023066673324
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.0027933000000000003	0.051117023066673324
#612645 DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B	0.0027933000000000003	0.051117023066673324
#300914 DEAFNESS, X-LINKED 6; DFNX6	0.0027933000000000003	0.051117023066673324
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.0027933000000000003	0.051117023066673324
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.0027933000000000003	0.051117023066673324
OHDO SYNDROME	0.0027933000000000003	0.051117023066673324
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0027933000000000003	0.051117023066673324
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0027933000000000003	0.051117023066673324
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.0027933000000000003	0.051117023066673324
DEAFNESS, X-LINKED 5; DFNX5	0.0027933000000000003	0.051117023066673324
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.0027933000000000003	0.051117023066673324
DEAFNESS-CRANIOFACIAL SYNDROME	0.0027933000000000003	0.051117023066673324
BARAITSER-WINTER SYNDROME 2; BRWS2	0.0027933000000000003	0.051117023066673324
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.0027933000000000003	0.051117023066673324
KLEEFSTRA SYNDROME	0.0027933000000000003	0.051117023066673324
#614614 DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B	0.0027933000000000003	0.051117023066673324
#600971 DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 6; NSRD6	0.0027933000000000003	0.051117023066673324
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.0027933000000000003	0.051117023066673324
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.0027933000000000003	0.051117023066673324
HARDIKAR SYNDROME	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.0027933000000000003	0.051117023066673324
PULMONIC STENOSIS AND DEAFNESS	0.0027933000000000003	0.051117023066673324
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.0027933000000000003	0.051117023066673324
CHIARI MALFORMATION TYPE I	0.0027933000000000003	0.051117023066673324
BRITTLE CORNEA SYNDROME	0.0027933000000000003	0.051117023066673324
#614899 DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93	0.0027933000000000003	0.051117023066673324
#615629 DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56	0.0027933000000000003	0.051117023066673324
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.0027933000000000003	0.051117023066673324
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0027933000000000003	0.051117023066673324
SPINOCEREBELLAR ATAXIA 13	0.0027933000000000003	0.051117023066673324
#614896 SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD	0.0027933000000000003	0.051117023066673324
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.051117023066673324
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0027933000000000003	0.051117023066673324
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0027933000000000003	0.051117023066673324
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.0027933000000000003	0.051117023066673324
Adrenoleukodystrophy	0.0027933000000000003	0.051117023066673324
184705 STEINFELD SYNDROME	0.0027933000000000003	0.051117023066673324
RAPADILINO SYNDROME	0.0027933000000000003	0.051117023066673324
CHARGE-LIKE SYNDROME, X-LINKED	0.0027933000000000003	0.051117023066673324
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0027933000000000003	0.051117023066673324
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.0027933000000000003	0.051117023066673324
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.0027933000000000003	0.051117023066673324
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0027933000000000003	0.051117023066673324
USHER SYNDROME, TYPE IID; USH2D	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.0027933000000000003	0.051117023066673324
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.0027933000000000003	0.051117023066673324
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.0027933000000000003	0.051117023066673324
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.0027933000000000003	0.051117023066673324
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.0027933000000000003	0.051117023066673324
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00254453	0.04656456474558489
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00254453	0.04656456474558489
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00254453	0.04656456474558489
#606705 DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36	0.00254453	0.04656456474558489
#262000 BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00254453	0.04656456474558489
KEARNS-SAYRE SYNDROME; KSS	0.00254453	0.04656456474558489
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00254453	0.04656456474558489
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00254453	0.04656456474558489
STICKLER SYNDROME, TYPE V; STL5	0.00254453	0.04656456474558489
KEIPERT SYNDROME; KPTS	0.00254453	0.04656456474558489
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00254453	0.04656456474558489
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00254453	0.04656456474558489
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00254453	0.04656456474558489
OTODENTAL DYSPLASIA	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00254453	0.04656456474558489
#616357 DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40	0.00254453	0.04656456474558489
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00254453	0.04656456474558489
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00254453	0.04656456474558489
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00254453	0.04656456474558489
#603629 DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21	0.00254453	0.04656456474558489
PERRAULT SYNDROME 2; PRLTS2	0.00254453	0.04656456474558489
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00254453	0.04656456474558489
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00254453	0.04656456474558489
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.00254453	0.04656456474558489
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00254453	0.04656456474558489
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00254453	0.04656456474558489
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00254453	0.04656456474558489
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00254453	0.04656456474558489
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00254453	0.04656456474558489
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.00254453	0.04656456474558489
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00254453	0.04656456474558489
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00254453	0.04656456474558489
USHER SYNDROME, TYPE IG	0.00254453	0.04656456474558489
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00254453	0.04656456474558489
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.00254453	0.04656456474558489
#607084 DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31;;WHIRLER, MOUSE, HOMOLOG OF	0.00254453	0.04656456474558489
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00254453	0.04656456474558489
OPTIC ATROPHY 8	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00254453	0.04656456474558489
#154780 MARSHALL SYNDROME; MRSHS	0.00254453	0.04656456474558489
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00254453	0.04656456474558489
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00254453	0.04656456474558489
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00254453	0.04656456474558489
DEAFNESS, X-LINKED 1	0.00254453	0.04656456474558489
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00254453	0.04656456474558489
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00254453	0.04656456474558489
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00254453	0.04656456474558489
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00254453	0.04656456474558489
#118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS;;CHARCOT-MARIE-TOOTH NEUROPATHY AND DEAFNESS, AUTOSOMAL DOMINANT;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1E; CMT1E	0.00254453	0.04656456474558489
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00254453	0.04656456474558489
WOLFRAM SYNDROME 2; WFS2	0.00254453	0.04656456474558489
#220290 DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1ADEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED;;DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED	0.00254453	0.04656456474558489
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00254453	0.04656456474558489
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00254453	0.04656456474558489
FRONTOMETAPHYSEAL DYSPLASIA	0.00254453	0.04656456474558489
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00254453	0.04656456474558489
Deafness, autosomal recessive 113	0.00254453	0.04656456474558489
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00254453	0.04656456474558489
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.00254453	0.04656456474558489
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00254453	0.04656456474558489
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00254453	0.04656456474558489
#613865 DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61	0.00254453	0.04656456474558489
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00254453	0.04656456474558489
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00254453	0.04656456474558489
USHER SYNDROME, TYPE IIIA	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00254453	0.04656456474558489
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00254453	0.04656456474558489
#609006 DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT;DFNB36DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT, INCLUDED	0.00254453	0.04656456474558489
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00254453	0.04656456474558489
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00254453	0.04656456474558489
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00254453	0.04656456474558489
IMMUNODEFICIENCY 47	0.00254453	0.04656456474558489
#616340 DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67	0.00254453	0.04656456474558489
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00254453	0.04656456474558489
#607039 DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22	0.00254453	0.04656456474558489
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.00254453	0.04656456474558489
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00254453	0.04656456474558489
NASODIGITOACOUSTIC SYNDROME	0.00254453	0.04656456474558489
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00254453	0.04656456474558489
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.00254453	0.04656456474558489
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00254453	0.04656456474558489
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.00254453	0.04656456474558489
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00254453	0.04656456474558489
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00254453	0.04656456474558489
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.00254453	0.04656456474558489
#609706 DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53	0.00254453	0.04656456474558489
#608565 DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35	0.00254453	0.04656456474558489
HYPERLEUCINE-ISOLEUCINEMIA	0.00254453	0.04656456474558489
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00254453	0.04656456474558489
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.00254453	0.04656456474558489
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00254453	0.04656456474558489
ENLARGED VESTIBULAR AQUEDUCT	0.00254453	0.04656456474558489
DEAFNESS, Y-LINKED 1	0.00254453	0.04656456474558489
MENTAL RETARDATION, X-LINKED 46	0.00254453	0.04656456474558489
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00254453	0.04656456474558489
DEAFNESS, Y-LINKED 2; DFNY2	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00254453	0.04656456474558489
STICKLER SYNDROME, TYPE III	0.00254453	0.04656456474558489
#607453 DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00254453	0.04656456474558489
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00254453	0.04656456474558489
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00254453	0.04656456474558489
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00254453	0.04656456474558489
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00254453	0.04656456474558489
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00254453	0.04656456474558489
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00254453	0.04656456474558489
#608389 BRANCHIOOTIC SYNDROME 3; BOS3;;BO SYNDROME 3	0.00254453	0.04656456474558489
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00254453	0.04656456474558489
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00254453	0.04656456474558489
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00254453	0.04656456474558489
THYROCEREBRORETINAL SYNDROME	0.00254453	0.04656456474558489
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00254453	0.04656456474558489
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00254453	0.04656456474558489
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00254453	0.04656456474558489
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00254453	0.04656456474558489
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.00254453	0.04656456474558489
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00254453	0.04656456474558489
#607841 DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48	0.00254453	0.04656456474558489
#614861 DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98	0.00254453	0.04656456474558489
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00254453	0.04656456474558489
#234580 HEIMLER SYNDROME 1; HMLR1;;HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS;;PEROXISOME BIOGENESIS DISORDER 1C; PBD1C	0.00254453	0.04656456474558489
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00254453	0.04656456474558489
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00254453	0.04656456474558489
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00254453	0.04656456474558489
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00254453	0.04656456474558489
#601536 ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS;;NAVAJO BRAINSTEM SYNDROMEBOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	0.00254453	0.04656456474558489
RETINITIS PIGMENTOSA 59; RP59	0.00254453	0.04656456474558489
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.00254453	0.04656456474558489
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00254453	0.04656456474558489
FOUNTAIN SYNDROME	0.00254453	0.04656456474558489
ERMINE PHENOTYPE	0.00254453	0.04656456474558489
Deafness, autosomal recessive 99	0.00254453	0.04656456474558489
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00254453	0.04656456474558489
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00254453	0.04656456474558489
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00254453	0.04656456474558489
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00254453	0.04656456474558489
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00254453	0.04656456474558489
#613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC	0.00254453	0.04656456474558489
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00254453	0.04656456474558489
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00254453	0.04656456474558489
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00254453	0.04656456474558489
BRACHYDACTYLY, TYPE B2	0.00254453	0.04656456474558489
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00254453	0.04656456474558489
WOODHOUSE-SAKATI SYNDROME	0.00254453	0.04656456474558489
HAMAMY SYNDROME; HMMS	0.00254453	0.04656456474558489
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00254453	0.04656456474558489
WAARDENBURG SYNDROME, TYPE IIB	0.00254453	0.04656456474558489
#610220 DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59	0.00254453	0.04656456474558489
SPINOCEREBELLAR ATAXIA 31	0.00254453	0.04656456474558489
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00254453	0.04656456474558489
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00254453	0.04656456474558489
#609057 NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	0.00254453	0.04656456474558489
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00254453	0.04656456474558489
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00254453	0.04656456474558489
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00254453	0.04656456474558489
Split hand/foot malformation 1 (SHFM1)	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00254453	0.04656456474558489
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00254453	0.04656456474558489
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00254453	0.04656456474558489
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00254453	0.04656456474558489
OPTIC ATROPHY 1; OPA1	0.00248756	0.04552202122927501
SECKEL SYNDROME 1; SCKL1	0.00248756	0.04552202122927501
VITREORETINOCHOROIDOPATHY; VRCP	0.00248756	0.04552202122927501
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00248756	0.04552202122927501
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00248756	0.04552202122927501
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00248756	0.04552202122927501
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00248756	0.04552202122927501
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00248756	0.04552202122927501
#610427 CONE-ROD SYNAPTIC DISORDER, CONGENITAL NONPROGRESSIVE; CRSD;;NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 2B, FORMERLY; CSNB2B,FORMERLY;;NIGHT BLINDNESS, CONGENITAL STATIONARY, INCOMPLETE, AUTOSOMAL RECESSIVE,FORMERLY	0.00248756	0.04552202122927501
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00248756	0.04552202122927501
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.00248756	0.04552202122927501
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00248756	0.04552202122927501
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.00248756	0.04552202122927501
#214500 CHEDIAK-HIGASHI SYNDROME; CHS	0.00248756	0.04552202122927501
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00248756	0.04552202122927501
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00248756	0.04552202122927501
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.00248756	0.04552202122927501
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.00248756	0.04552202122927501
CHROMOSOME 3q13.31 DELETION SYNDROME	0.00248756	0.04552202122927501
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00248756	0.04552202122927501
SMITH-KINGSMORE SYNDROME; SKS	0.00248756	0.04552202122927501
ABDUCENS PALSY	0.00248756	0.04552202122927501
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.00248756	0.04552202122927501
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00248756	0.04552202122927501
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00248756	0.04552202122927501
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00248756	0.04552202122927501
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00248756	0.04552202122927501
#608470 CORNEAL DYSTROPHY OF BOWMAN LAYER, TYPE I; CDB1;;CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB;;REIS-BUCKLERS CORNEAL DYSTROPHY; RBCD;;CORNEAL DYSTROPHY, GEOGRAPHIC;;GRANULAR CORNEAL DYSTROPHY, TYPE III	0.00248756	0.04552202122927501
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00248756	0.04552202122927501
JACOBSEN SYNDROME	0.00248756	0.04552202122927501
#613216 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1C; CSNB1C;;CSNB, COMPLETE, AUTOSOMAL RECESSIVE	0.00248756	0.04552202122927501
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.00248756	0.04552202122927501
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00248756	0.04552202122927501
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00248756	0.04552202122927501
LAMBOTTE SYNDROME	0.00248756	0.04552202122927501
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00248756	0.04552202122927501
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.00248756	0.04552202122927501
MENTAL RETARDATION, X-LINKED 1	0.00248756	0.04552202122927501
NEPHRONOPHTHISIS 18; NPHP18	0.00248756	0.04552202122927501
SPASTIC PARAPLEGIA 16, X-LINKED	0.00248756	0.04552202122927501
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.00248756	0.04552202122927501
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00248756	0.04552202122927501
GAPO SYNDROME; GAPOS	0.00248756	0.04552202122927501
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.00248756	0.04552202122927501
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00248756	0.04552202122927501
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.00248756	0.04552202122927501
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00248756	0.04552202122927501
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00248756	0.04552202122927501
#248250 HYPOMAGNESEMIA 3, RENAL; HOMG3;;HYPOMAGNESEMIA, PRIMARY, DUE TO DEFECT IN RENAL TUBULAR TRANSPORTOF MAGNESIUM;;HYPOMAGNESEMIA, ISOLATED RENAL;;HYPOMAGNESEMIA, FAMILIAL, WITH HYPERCALCIURIA AND NEPHROCALCINOSISHYPERCALCIURIA, CHILDHOOD, SELF-LIMITING, INCLUDED	0.00248756	0.04552202122927501
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00248756	0.04552202122927501
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.00248756	0.04552202122927501
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.00248756	0.04552202122927501
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00248756	0.04552202122927501
PITT-HOPKINS SYNDROME	0.00248756	0.04552202122927501
SENGERS SYNDROME	0.00248756	0.04552202122927501
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00248756	0.04552202122927501
SECKEL SYNDROME 5; SCKL5	0.00248756	0.04552202122927501
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00248756	0.04552202122927501
PETERS ANOMALY	0.00248756	0.04552202122927501
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00248756	0.04552202122927501
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00248756	0.04552202122927501
SOTOS SYNDROME 2	0.00248756	0.04552202122927501
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00248756	0.04552202122927501
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.00248756	0.04552202122927501
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00248756	0.04552202122927501
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.00248756	0.04552202122927501
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.00248756	0.04552202122927501
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00248756	0.04552202122927501
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00248756	0.04552202122927501
#613151 MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION),TYPE B, 3; MDDGB3;;MUSCULAR DYSTROPHY, CONGENITAL, POMGNT1-RELATED	0.00248756	0.04552202122927501
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00248756	0.04552202122927501
GAUCHER DISEASE, TYPE IIIC	0.00248756	0.04552202122927501
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00248756	0.04552202122927501
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00248756	0.04552202122927501
RETINAL CONE DYSTROPHY 3B	0.00248756	0.04552202122927501
#613227 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME3; CAMRQ3;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 3	0.00248756	0.04552202122927501
#613561 MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 2; MLASA2	0.00248756	0.04552202122927501
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00248756	0.04552202122927501
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00248756	0.04552202122927501
#614199 NEPHROTIC SYNDROME, TYPE 5, WITH OR WITHOUT OCULAR ABNORMALITIES;NPHS5	0.00248756	0.04552202122927501
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.00248756	0.04552202122927501
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00248756	0.04552202122927501
GLUTATHIONURIA	0.00248756	0.04552202122927501
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00248756	0.04552202122927501
ROBINOW-SORAUF SYNDROME	0.00248756	0.04552202122927501
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00248756	0.04552202122927501
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00248756	0.04552202122927501
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00248756	0.04552202122927501
#610048 CORNEAL DYSTROPHY, CONGENITAL STROMAL; CSCD;;CONGENITAL STROMAL CORNEAL DYSTROPHY	0.00248756	0.04552202122927501
#615058 NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1F; CSNB1F	0.00248756	0.04552202122927501
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00248756	0.04552202122927501
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00248756	0.04552202122927501
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.00248756	0.04552202122927501
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000843882	0.015442929746017403
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.015442929746017403
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.000843882	0.015442929746017403
JOUBERT SYNDROME 24	0.000843882	0.015442929746017403
RING CHROMOSOME 14 SYNDROME	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000843882	0.015442929746017403
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000843882	0.015442929746017403
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000843882	0.015442929746017403
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000843882	0.015442929746017403
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.015442929746017403
CHROMOSOME 16Q22 DELETION SYNDROME	0.000843882	0.015442929746017403
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.015442929746017403
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.000843882	0.015442929746017403
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.015442929746017403
ADAMS-OLIVER SYNDROME 1; AOS1	0.000843882	0.015442929746017403
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000843882	0.015442929746017403
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000843882	0.015442929746017403
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.000843882	0.015442929746017403
Cerebral creatine deficiency syndrome 2	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000843882	0.015442929746017403
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000843882	0.015442929746017403
TEMPLE-BARAITSER SYNDROME; TMBTS	0.000843882	0.015442929746017403
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000843882	0.015442929746017403
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.000843882	0.015442929746017403
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000843882	0.015442929746017403
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000843882	0.015442929746017403
GRISCELLI SYNDROME, TYPE 1	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000843882	0.015442929746017403
JOUBERT SYNDROME 17; JBTS17	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000843882	0.015442929746017403
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000843882	0.015442929746017403
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000843882	0.015442929746017403
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.015442929746017403
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000843882	0.015442929746017403
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.000843882	0.015442929746017403
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000843882	0.015442929746017403
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.000843882	0.015442929746017403
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.000843882	0.015442929746017403
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.015442929746017403
OROTIC ACIDURIA	0.000843882	0.015442929746017403
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000843882	0.015442929746017403
FOLATE MALABSORPTION, HEREDITARY	0.000843882	0.015442929746017403
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.000843882	0.015442929746017403
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.015442929746017403
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000843882	0.015442929746017403
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000843882	0.015442929746017403
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000843882	0.015442929746017403
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.015442929746017403
COACH SYNDROME	0.000843882	0.015442929746017403
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.015442929746017403
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000843882	0.015442929746017403
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000843882	0.015442929746017403
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000843882	0.015442929746017403
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000843882	0.015442929746017403
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000843882	0.015442929746017403
CURRY-JONES SYNDROME	0.000843882	0.015442929746017403
COFFIN-SIRIS SYNDROME 5	0.000843882	0.015442929746017403
Cerebral creatine deficiency syndrome 3	0.000843882	0.015442929746017403
HEART AND BRAIN MALFORMATION SYNDROME	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000843882	0.015442929746017403
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000843882	0.015442929746017403
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.015442929746017403
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000843882	0.015442929746017403
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.000843882	0.015442929746017403
NETHERTON SYNDROME; NETH	0.000843882	0.015442929746017403
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.015442929746017403
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.000843882	0.015442929746017403
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000843882	0.015442929746017403
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.015442929746017403
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000843882	0.015442929746017403
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.000843882	0.015442929746017403
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.000843882	0.015442929746017403
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000843882	0.015442929746017403
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.000843882	0.015442929746017403
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.015442929746017403
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.015442929746017403
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.015442929746017403
#614483 PORENCEPHALY 2; POREN2	0.000843882	0.015442929746017403
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000843882	0.015442929746017403
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000843882	0.015442929746017403
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000843882	0.015442929746017403
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000843882	0.015442929746017403
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.015442929746017403
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000843882	0.015442929746017403
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000843882	0.015442929746017403
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.015442929746017403
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.015442929746017403
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000843882	0.015442929746017403
Bardet-Biedl syndrome 2	0.000843882	0.015442929746017403
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000843882	0.015442929746017403
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.015442929746017403
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000843882	0.015442929746017403
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000843882	0.015442929746017403
GOLDBERG-SHPRINTZEN SYNDROME	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000843882	0.015442929746017403
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000843882	0.015442929746017403
DIAMOND-BLACKFAN ANEMIA 5	0.000843882	0.015442929746017403
Congenital disorder of glycosylation, type IIh	0.000843882	0.015442929746017403
LOWRY-MACLEAN SYNDROME	0.000843882	0.015442929746017403
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000843882	0.015442929746017403
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000843882	0.015442929746017403
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.015442929746017403
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.000843882	0.015442929746017403
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000843882	0.015442929746017403
HOLOPROSENCEPHALY 7	0.000843882	0.015442929746017403
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.015442929746017403
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.015442929746017403
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000843882	0.015442929746017403
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.015442929746017403
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED 72	0.000843882	0.015442929746017403
PYRUVATE CARBOXYLASE DEFICIENCY	0.000843882	0.015442929746017403
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.000843882	0.015442929746017403
LISSENCEPHALY 4	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000843882	0.015442929746017403
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.000843882	0.015442929746017403
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.015442929746017403
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.015442929746017403
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.000843882	0.015442929746017403
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000843882	0.015442929746017403
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000843882	0.015442929746017403
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.015442929746017403
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.015442929746017403
JOUBERT SYNDROME 25	0.000843882	0.015442929746017403
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000843882	0.015442929746017403
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.000843882	0.015442929746017403
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.015442929746017403
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.015442929746017403
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000843882	0.015442929746017403
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.015442929746017403
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.000843882	0.015442929746017403
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.015442929746017403
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000843882	0.015442929746017403
AICARDI-GOUTIERES SYNDROME 5	0.000843882	0.015442929746017403
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.015442929746017403
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.000843882	0.015442929746017403
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.000843882	0.015442929746017403
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000843882	0.015442929746017403
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.015442929746017403
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.000843882	0.015442929746017403
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000843882	0.015442929746017403
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.015442929746017403
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.000843882	0.015442929746017403
DYSTONIA 28, CHILDHOOD-ONSET	0.000843882	0.015442929746017403
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.015442929746017403
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000843882	0.015442929746017403
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.000843882	0.015442929746017403
NOONAN SYNDROME 9; NS9	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000843882	0.015442929746017403
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000843882	0.015442929746017403
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000843882	0.015442929746017403
KETOADIPICACIDURIA	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000843882	0.015442929746017403
JOUBERT SYNDROME 8	0.000843882	0.015442929746017403
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000843882	0.015442929746017403
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000843882	0.015442929746017403
IMMUNODEFICIENCY 49; IMD49	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000843882	0.015442929746017403
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.015442929746017403
JOUBERT SYNDROME 27	0.000843882	0.015442929746017403
HOLOPROSENCEPHALY 2; HPE2	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000843882	0.015442929746017403
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.015442929746017403
CHROMOSOME 5Q12 DELETION SYNDROME	0.000843882	0.015442929746017403
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.015442929746017403
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.015442929746017403
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.015442929746017403
LANDAU-KLEFFNER SYNDROME	0.000843882	0.015442929746017403
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000843882	0.015442929746017403
LUSCAN-LUMISH SYNDROME; LLS	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED 103	0.000843882	0.015442929746017403
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.015442929746017403
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.015442929746017403
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000843882	0.015442929746017403
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.015442929746017403
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.015442929746017403
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000843882	0.015442929746017403
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.000843882	0.015442929746017403
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000843882	0.015442929746017403
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000843882	0.015442929746017403
PEHO SYNDROME; PEHO	0.000843882	0.015442929746017403
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED 41	0.000843882	0.015442929746017403
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000843882	0.015442929746017403
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.015442929746017403
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.015442929746017403
TEMTAMY SYNDROME; TEMTYS	0.000843882	0.015442929746017403
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000843882	0.015442929746017403
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.015442929746017403
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.000843882	0.015442929746017403
Xq28 (MECP2) duplication	0.000843882	0.015442929746017403
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000843882	0.015442929746017403
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000843882	0.015442929746017403
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.015442929746017403
#300555 DENT DISEASE 2	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.015442929746017403
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.015442929746017403
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000843882	0.015442929746017403
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.015442929746017403
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000843882	0.015442929746017403
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000843882	0.015442929746017403
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.015442929746017403
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.015442929746017403
CEREBELLOFACIODENTAL SYNDROME	0.000843882	0.015442929746017403
POPOV-CHANG SYNDROME; POPCHAS	0.000843882	0.015442929746017403
HARTNUP DISORDER	0.000843882	0.015442929746017403
OGDEN SYNDROME; OGDNS	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.000843882	0.015442929746017403
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.000843882	0.015442929746017403
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.015442929746017403
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000843882	0.015442929746017403
HARTSFIELD SYNDROME; HRTFDS	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED 9	0.000843882	0.015442929746017403
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000843882	0.015442929746017403
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000843882	0.015442929746017403
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000843882	0.015442929746017403
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.000843882	0.015442929746017403
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000843882	0.015442929746017403
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.015442929746017403
ADAMS-OLIVER SYNDROME 3; AOS3	0.000843882	0.015442929746017403
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.000843882	0.015442929746017403
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.015442929746017403
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000843882	0.015442929746017403
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000843882	0.015442929746017403
JOUBERT SYNDROME 30; JBTS30	0.000843882	0.015442929746017403
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000843882	0.015442929746017403
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.015442929746017403
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000843882	0.015442929746017403
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000843882	0.015442929746017403
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000843882	0.015442929746017403
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.000843882	0.015442929746017403
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000843882	0.015442929746017403
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.000843882	0.015442929746017403
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000843882	0.015442929746017403
EVEN-PLUS SYNDROME	0.000843882	0.015442929746017403
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.000843882	0.015442929746017403
AICARDI-GOUTIERES SYNDROME 7	0.000843882	0.015442929746017403
SEPTOOPTIC DYSPLASIA	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000843882	0.015442929746017403
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000843882	0.015442929746017403
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.015442929746017403
JOUBERT SYNDROME 26	0.000843882	0.015442929746017403
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000843882	0.015442929746017403
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.000843882	0.015442929746017403
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000843882	0.015442929746017403
COFFIN-SIRIS SYNDROME 2; CSS2	0.000843882	0.015442929746017403
ALAZAMI-YUAN SYNDROME	0.000843882	0.015442929746017403
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000843882	0.015442929746017403
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.015442929746017403
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.015442929746017403
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000843882	0.015442929746017403
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.000843882	0.015442929746017403
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000843882	0.015442929746017403
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000843882	0.015442929746017403
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.015442929746017403
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.000843882	0.015442929746017403
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.015442929746017403
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.015442929746017403
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.000843882	0.015442929746017403
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000843882	0.015442929746017403
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000843882	0.015442929746017403
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.015442929746017403
GRACILE BONE DYSPLASIA; GCLEB	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000843882	0.015442929746017403
HOLOPROSENCEPHALY 1; HPE1	0.000843882	0.015442929746017403
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.015442929746017403
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000843882	0.015442929746017403
ARIMA SYNDROME	0.000843882	0.015442929746017403
AU-KLINE SYNDROME; AUKS	0.000843882	0.015442929746017403
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.015442929746017403
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.000843882	0.015442929746017403
XQ25 DUPLICATION SYNDROME	0.000843882	0.015442929746017403
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.015442929746017403
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000843882	0.015442929746017403
BETA-UREIDOPROPIONASE DEFICIENCY	0.000843882	0.015442929746017403
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000843882	0.015442929746017403
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.015442929746017403
Leukotriene C4 synthase deficiency	0.000843882	0.015442929746017403
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.015442929746017403
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000843882	0.015442929746017403
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000843882	0.015442929746017403
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.015442929746017403
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000843882	0.015442929746017403
XIA-GIBBS SYNDROME	0.000843882	0.015442929746017403
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.015442929746017403
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000843882	0.015442929746017403
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.000843882	0.015442929746017403
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.000843882	0.015442929746017403
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000843882	0.015442929746017403
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000843882	0.015442929746017403
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.000843882	0.015442929746017403
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000843882	0.015442929746017403
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000843882	0.015442929746017403
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000843882	0.015442929746017403
Jawad syndrome	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.015442929746017403
CREE MENTAL RETARDATION SYNDROME	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000843882	0.015442929746017403
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000843882	0.015442929746017403
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000843882	0.015442929746017403
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000843882	0.015442929746017403
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.000843882	0.015442929746017403
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000843882	0.015442929746017403
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.000843882	0.015442929746017403
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000843882	0.015442929746017403
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000843882	0.015442929746017403
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000843882	0.015442929746017403
DIGEORGE SYNDROME; DGS	0.000843882	0.015442929746017403
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000843882	0.015442929746017403
WEBB-DATTANI SYNDROME; WEDAS	0.000843882	0.015442929746017403
BARDET-BIEDL SYNDROME 8; BBS8	0.000843882	0.015442929746017403
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000843882	0.015442929746017403
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000843882	0.015442929746017403
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000843882	0.015442929746017403
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000843882	0.015442929746017403
LISSENCEPHALY 2; LIS2	0.000843882	0.015442929746017403
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000843882	0.015442929746017403
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.000843882	0.015442929746017403
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000843882	0.015442929746017403
JOUBERT SYNDROME 28	0.000843882	0.015442929746017403
HOLOPROSENCEPHALY 11	0.000843882	0.015442929746017403
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000843882	0.015442929746017403
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.015442929746017403
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.000843882	0.015442929746017403
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.000843882	0.015442929746017403
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000843882	0.015442929746017403
SALLA DISEASE	0.000843882	0.015442929746017403
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000843882	0.015442929746017403
%300712 CRANIOFACIOSKELETAL SYNDROME	0.000843882	0.015442929746017403
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.015442929746017403
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.015442929746017403
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000843882	0.015442929746017403
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000843882	0.015442929746017403
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.015442929746017403
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.015442929746017403
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.000843882	0.015442929746017403
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000843882	0.015442929746017403
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000843882	0.015442929746017403
JOUBERT SYNDROME 10	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000843882	0.015442929746017403
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.000843882	0.015442929746017403
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.000843882	0.015442929746017403
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000843882	0.015442929746017403
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.000843882	0.015442929746017403
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.000843882	0.015442929746017403
FRIAS SYNDROME	0.000843882	0.015442929746017403
CHROMOSOME 15Q14 DELETION SYNDROME	0.000843882	0.015442929746017403
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000843882	0.015442929746017403
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.015442929746017403
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.015442929746017403
HYPERPROLINEMIA, TYPE I	0.000843882	0.015442929746017403
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.015442929746017403
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.000843882	0.015442929746017403
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000843882	0.015442929746017403
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.015442929746017403
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.000843882	0.015442929746017403
AUSTRALIA ANTIGEN	0.000843882	0.015442929746017403
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000843882	0.015442929746017403
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000843882	0.015442929746017403
PEHO-LIKE SYNDROME; PEHOL	0.000843882	0.015442929746017403
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.000843882	0.015442929746017403
JOUBERT SYNDROME 6	0.000843882	0.015442929746017403
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000843882	0.015442929746017403
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000843882	0.015442929746017403
611961 STEVENSON-CAREY SYNDROME	0.000843882	0.015442929746017403
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000843882	0.015442929746017403
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000843882	0.015442929746017403
SHUKLA-VERNON SYNDROME; SHUVER	0.000843882	0.015442929746017403
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000843882	0.015442929746017403
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000843882	0.015442929746017403
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.015442929746017403
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.015442929746017403
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000843882	0.015442929746017403
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000843882	0.015442929746017403
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.000843882	0.015442929746017403
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000843882	0.015442929746017403
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000843882	0.015442929746017403
CRANIOFRONTONASAL SYNDROME; CFNS	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000843882	0.015442929746017403
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.000843882	0.015442929746017403
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000843882	0.015442929746017403
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.015442929746017403
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.015442929746017403
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000843882	0.015442929746017403
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.000843882	0.015442929746017403
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.015442929746017403
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.000843882	0.015442929746017403
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000843882	0.015442929746017403
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.000843882	0.015442929746017403
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000843882	0.015442929746017403
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.000843882	0.015442929746017403
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.015442929746017403
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.015442929746017403
GLASS SYNDROME	0.000843882	0.015442929746017403
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.000843882	0.015442929746017403
JOUBERT SYNDROME 15	0.000843882	0.015442929746017403
REVESZ SYNDROME	0.000843882	0.015442929746017403
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000843882	0.015442929746017403
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.000843882	0.015442929746017403
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000843882	0.015442929746017403
ELEJALDE DISEASE	0.000843882	0.015442929746017403
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000843882	0.015442929746017403
WAISMAN SYNDROME; WSMN	0.000843882	0.015442929746017403
CHROMOSOME 9P DELETION SYNDROME	0.000843882	0.015442929746017403
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.015442929746017403
SULFOCYSTEINURIA	0.000843882	0.015442929746017403
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.015442929746017403
TIMOTHY SYNDROME; TS	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000843882	0.015442929746017403
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000843882	0.015442929746017403
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000843882	0.015442929746017403
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000843882	0.015442929746017403
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.015442929746017403
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000843882	0.015442929746017403
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000843882	0.015442929746017403
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000843882	0.015442929746017403
MENTAL RETARDATION, X-LINKED 88	0.000843882	0.015442929746017403
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000843882	0.015442929746017403
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000843882	0.015442929746017403
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.015442929746017403
RITSCHER-SCHINZEL SYNDROME 1	0.000843882	0.015442929746017403
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000843882	0.015442929746017403
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.000843882	0.015442929746017403
SECKEL SYNDROME 9; SCKL9	0.000843882	0.015442929746017403
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000843882	0.015442929746017403
AL-RAQAD SYNDROME; ARS	0.000843882	0.015442929746017403
CHROMOSOME 18P DELETION SYNDROME	0.000843882	0.015442929746017403
TARP SYNDROME; TARPS	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.015442929746017403
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.015442929746017403
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000843882	0.015442929746017403
MECKEL SYNDROME 13; MKS13	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000843882	0.015442929746017403
MACDERMOT-WINTER SYNDROME	0.000843882	0.015442929746017403
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.015442929746017403
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.015442929746017403
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000843882	0.015442929746017403
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.015442929746017403
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000843882	0.015442929746017403
CULLER-JONES SYNDROME; CJS	0.000843882	0.015442929746017403
NIEMANN-PICK DISEASE, TYPE C2	0.000843882	0.015442929746017403
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000843882	0.015442929746017403
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.000843882	0.015442929746017403
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000843882	0.015442929746017403
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.015442929746017403
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000843882	0.015442929746017403
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.015442929746017403
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.015442929746017403
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.015442929746017403
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000843882	0.015442929746017403
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.000843882	0.015442929746017403
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.015442929746017403
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000843882	0.015442929746017403
LISSENCEPHALY 1; LIS1	0.000843882	0.015442929746017403
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.015442929746017403
